Application and synthesis of thiazole ring in clinically approved drugs
The development of heterocyclic derivatives has progressed considerably over the past few decades, and many new agents of synthetic and natural origin have been produced. Among heterocyclic compounds, thiazole is a unique five-membered heterocyclic motif characterized by nitrogen and sulfur atoms, w...
Saved in:
| Published in | European journal of medicinal chemistry Vol. 250; p. 115172 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
France
Elsevier Masson SAS
15.03.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The development of heterocyclic derivatives has progressed considerably over the past few decades, and many new agents of synthetic and natural origin have been produced. Among heterocyclic compounds, thiazole is a unique five-membered heterocyclic motif characterized by nitrogen and sulfur atoms, which is widely used as an important core skeleton in a variety of pharmaceutically important compounds due to their diverse biological activities, such as antibacterial, antivirus, and antifungal. To the best of our knowledge, more than 90 thiazole-containing derivatives have been currently under clinical investigation, and some thiazole analogs have been approved to treat various diseases. As the potentially privileged scaffolds, thiazole derivatives can be further extensively explored to search for new drugs characterized by improved therapeutic efficacy and similar biological targets. This review aims to outline the applications and synthetic routes of some representative thiazole-containing drugs approved in the clinic, which may guide medicinal researchers to rationally design more effective thiazole-containing drug candidates.
[Display omitted]
•Thiazole ring is widely used in many drugs to treat various diseases.•Recent advances in thiazole-containing drugs have been summarized.•The clinical applications and synthetic routes of 33 thiazole-containing drugs are highlighted.•Summary and prospect are briefly discussed to guide future design of thiazole-containing drugs. |
|---|---|
| AbstractList | The development of heterocyclic derivatives has progressed considerably over the past few decades, and many new agents of synthetic and natural origin have been produced. Among heterocyclic compounds, thiazole is a unique five-membered heterocyclic motif characterized by nitrogen and sulfur atoms, which is widely used as an important core skeleton in a variety of pharmaceutically important compounds due to their diverse biological activities, such as antibacterial, antivirus, and antifungal. To the best of our knowledge, more than 90 thiazole-containing derivatives have been currently under clinical investigation, and some thiazole analogs have been approved to treat various diseases. As the potentially privileged scaffolds, thiazole derivatives can be further extensively explored to search for new drugs characterized by improved therapeutic efficacy and similar biological targets. This review aims to outline the applications and synthetic routes of some representative thiazole-containing drugs approved in the clinic, which may guide medicinal researchers to rationally design more effective thiazole-containing drug candidates. The development of heterocyclic derivatives has progressed considerably over the past few decades, and many new agents of synthetic and natural origin have been produced. Among heterocyclic compounds, thiazole is a unique five-membered heterocyclic motif characterized by nitrogen and sulfur atoms, which is widely used as an important core skeleton in a variety of pharmaceutically important compounds due to their diverse biological activities, such as antibacterial, antivirus, and antifungal. To the best of our knowledge, more than 90 thiazole-containing derivatives have been currently under clinical investigation, and some thiazole analogs have been approved to treat various diseases. As the potentially privileged scaffolds, thiazole derivatives can be further extensively explored to search for new drugs characterized by improved therapeutic efficacy and similar biological targets. This review aims to outline the applications and synthetic routes of some representative thiazole-containing drugs approved in the clinic, which may guide medicinal researchers to rationally design more effective thiazole-containing drug candidates.The development of heterocyclic derivatives has progressed considerably over the past few decades, and many new agents of synthetic and natural origin have been produced. Among heterocyclic compounds, thiazole is a unique five-membered heterocyclic motif characterized by nitrogen and sulfur atoms, which is widely used as an important core skeleton in a variety of pharmaceutically important compounds due to their diverse biological activities, such as antibacterial, antivirus, and antifungal. To the best of our knowledge, more than 90 thiazole-containing derivatives have been currently under clinical investigation, and some thiazole analogs have been approved to treat various diseases. As the potentially privileged scaffolds, thiazole derivatives can be further extensively explored to search for new drugs characterized by improved therapeutic efficacy and similar biological targets. This review aims to outline the applications and synthetic routes of some representative thiazole-containing drugs approved in the clinic, which may guide medicinal researchers to rationally design more effective thiazole-containing drug candidates. The development of heterocyclic derivatives has progressed considerably over the past few decades, and many new agents of synthetic and natural origin have been produced. Among heterocyclic compounds, thiazole is a unique five-membered heterocyclic motif characterized by nitrogen and sulfur atoms, which is widely used as an important core skeleton in a variety of pharmaceutically important compounds due to their diverse biological activities, such as antibacterial, antivirus, and antifungal. To the best of our knowledge, more than 90 thiazole-containing derivatives have been currently under clinical investigation, and some thiazole analogs have been approved to treat various diseases. As the potentially privileged scaffolds, thiazole derivatives can be further extensively explored to search for new drugs characterized by improved therapeutic efficacy and similar biological targets. This review aims to outline the applications and synthetic routes of some representative thiazole-containing drugs approved in the clinic, which may guide medicinal researchers to rationally design more effective thiazole-containing drug candidates. [Display omitted] •Thiazole ring is widely used in many drugs to treat various diseases.•Recent advances in thiazole-containing drugs have been summarized.•The clinical applications and synthetic routes of 33 thiazole-containing drugs are highlighted.•Summary and prospect are briefly discussed to guide future design of thiazole-containing drugs. |
| ArticleNumber | 115172 |
| Author | Wang, Ya-Tao Wang, Sai-Qi Liu, Hong-Min Li, Yan Chen, Xiao-Bing Niu, Zhen-Xi Zhang, Sheng-Nan |
| Author_xml | – sequence: 1 givenname: Zhen-Xi surname: Niu fullname: Niu, Zhen-Xi organization: Department of Pharmacy, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, 450018, China – sequence: 2 givenname: Ya-Tao surname: Wang fullname: Wang, Ya-Tao organization: First People's Hospital of Shangqiu, Henan Province, Shangqiu, 476100, China – sequence: 3 givenname: Sheng-Nan surname: Zhang fullname: Zhang, Sheng-Nan organization: Department of Pharmacy, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, 450018, China – sequence: 4 givenname: Yan surname: Li fullname: Li, Yan organization: Department of Pharmacy, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, 450018, China – sequence: 5 givenname: Xiao-Bing surname: Chen fullname: Chen, Xiao-Bing email: zlyychenxb0807@zzu.edu.cn organization: The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Henan Engineering Research Center of Precision Therapy of Gastrointestinal Cancer, Zhengzhou Key Laboratory for Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, China – sequence: 6 givenname: Sai-Qi surname: Wang fullname: Wang, Sai-Qi email: zlyywangsq3925@zzu.edu.cn organization: The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Henan Engineering Research Center of Precision Therapy of Gastrointestinal Cancer, Zhengzhou Key Laboratory for Precision Therapy of Gastrointestinal Cancer, Zhengzhou, 450008, China – sequence: 7 givenname: Hong-Min orcidid: 0000-0001-6771-9421 surname: Liu fullname: Liu, Hong-Min email: liuhm@zzu.edu.cn organization: School of Pharmaceutical Sciences & Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou University, Zhengzhou, 450001, China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36758304$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkLtOAzEQRS0EgvD4A4Rc0mzw2xsKJIR4SUg0UFuOPUscOd7F3iCFr2dhoaGAxtOce8dz9tF2ahMgdEzJlBKqzpZTWK7ALaaMMD6lVFLNttCEalVXnEmxjSaEMV5JxsUe2i9lSQiRipBdtMeVljUnYoJuL7suBmf70CZsk8dlk_oFlFBw2-B-Eex7GwHnkF5wSNjFkAY6xg22XZfbN_DY5_VLOUQ7jY0Fjr7nAXq-uX66uqseHm_vry4fKidY3VczUKp2Slk6d7WSw8saIZgWmjHqSaOtA0b5fOY5AUJdTaSTM8-Gb9dzIQg_QKdj77D8dQ2lN6tQHMRoE7TrYpjWUlGmZ_WAnnyj6_kKvOlyWNm8MT_HD8D5CLjclpKhMS70Xyb6bEM0lJhP02ZpRtPm07QZTQ9h8Sv80_9P7GKMwSDpLUA2xQVIDnzI4Hrj2_B3wQeNWpgq |
| CitedBy_id | crossref_primary_10_2174_0115680266292661240322072908 crossref_primary_10_1039_D3TA06022E crossref_primary_10_1080_00397911_2024_2387124 crossref_primary_10_55971_EJLS_1270394 crossref_primary_10_1016_j_ijbiomac_2024_136290 crossref_primary_10_1080_10426507_2023_2189253 crossref_primary_10_1002_ajoc_202300442 crossref_primary_10_1134_S1068162024030282 crossref_primary_10_1016_j_engmic_2024_100176 crossref_primary_10_1063_5_0246241 crossref_primary_10_1021_acs_jmedchem_4c01122 crossref_primary_10_1016_j_ejmech_2025_117526 crossref_primary_10_1021_acs_joc_3c01110 crossref_primary_10_1002_open_202400142 crossref_primary_10_1021_acs_orglett_4c04431 crossref_primary_10_1021_acs_orglett_4c01164 crossref_primary_10_1080_10406638_2025_2465568 crossref_primary_10_1016_j_bmcl_2024_130018 crossref_primary_10_1039_D4QO01233J crossref_primary_10_1002_slct_202304601 crossref_primary_10_1016_j_molstruc_2025_142150 crossref_primary_10_3390_ijms25073659 crossref_primary_10_1007_s10123_025_00636_9 crossref_primary_10_1002_cbdv_202400305 crossref_primary_10_1016_j_molstruc_2024_140475 crossref_primary_10_1021_acs_joc_3c02733 crossref_primary_10_3762_bjoc_20_202 crossref_primary_10_1016_j_poly_2023_116542 crossref_primary_10_1080_17425255_2024_2391389 crossref_primary_10_3390_antibiotics13080763 crossref_primary_10_1016_j_molstruc_2023_137374 crossref_primary_10_1002_slct_202405351 crossref_primary_10_1002_ardp_202400576 crossref_primary_10_3390_M1785 crossref_primary_10_1002_open_202400294 crossref_primary_10_1016_j_jphotochem_2024_115766 crossref_primary_10_1002_slct_202402565 crossref_primary_10_1021_acscatal_3c03497 crossref_primary_10_1016_j_actatropica_2023_106965 crossref_primary_10_1007_s10593_024_03348_6 crossref_primary_10_3390_ijms24108827 crossref_primary_10_1016_j_heliyon_2024_e41239 crossref_primary_10_1016_j_molliq_2024_124665 crossref_primary_10_1016_j_rechem_2024_101820 crossref_primary_10_1039_D4OB01388C crossref_primary_10_1080_17415993_2024_2338270 crossref_primary_10_2174_0113852728248762240812075831 crossref_primary_10_1021_acs_joc_4c02927 crossref_primary_10_1134_S1070363224120302 crossref_primary_10_1016_j_molliq_2025_127064 crossref_primary_10_1016_j_molstruc_2025_141354 crossref_primary_10_1080_07391102_2024_2306497 crossref_primary_10_2174_0115701786274678231124101033 crossref_primary_10_1016_j_molstruc_2024_138015 crossref_primary_10_1016_j_ejmech_2024_116219 crossref_primary_10_1002_slct_202404350 crossref_primary_10_1016_j_ejmech_2023_115689 crossref_primary_10_1016_j_indcrop_2024_119215 crossref_primary_10_6023_cjoc202310007 crossref_primary_10_1002_slct_202302803 crossref_primary_10_1039_D4MD00719K crossref_primary_10_1063_1674_0068_cjcp2309082 crossref_primary_10_1016_j_heliyon_2024_e31082 crossref_primary_10_1016_j_tetlet_2023_154787 crossref_primary_10_1021_acsinfecdis_3c00718 crossref_primary_10_1016_j_bioorg_2024_107451 crossref_primary_10_1021_acs_jafc_4c08185 crossref_primary_10_1134_S107036322402018X crossref_primary_10_1016_j_rechem_2024_101951 crossref_primary_10_3390_org6010001 crossref_primary_10_1039_D4CC02254H crossref_primary_10_1002_ejoc_202401020 crossref_primary_10_1016_j_arabjc_2024_105933 crossref_primary_10_1016_j_ejmech_2023_115452 crossref_primary_10_1080_22297928_2024_2355498 crossref_primary_10_3390_ph16091326 crossref_primary_10_1186_s13065_024_01284_2 crossref_primary_10_1080_00397911_2024_2399187 crossref_primary_10_3390_catal13091311 crossref_primary_10_1016_j_ejmech_2023_116107 crossref_primary_10_1016_j_molstruc_2024_139231 |
| Cites_doi | 10.1158/1538-7445.AM2018-4004 10.1158/1535-7163.MCT-08-0999 10.1128/AAC.05760-11 10.1128/AAC.01454-17 10.1016/S0021-5198(19)40053-X 10.1080/17512433.2019.1649137 10.1007/BF03256641 10.1016/j.ejphar.2017.02.046 10.1097/00008469-199702000-00010 10.1016/j.bmcl.2013.05.007 10.3390/molecules26113166 10.1007/BF01645372 10.1016/S0006-2952(99)00026-X 10.1371/journal.pone.0012041 10.1016/j.ejmech.2014.12.031 10.1136/bjo.73.7.574 10.1016/S1473-3099(07)70109-3 10.3390/molecules27133994 10.1074/jbc.M109.029470 10.1016/j.clinthera.2006.08.004 10.1002/jbt.22029 10.1016/j.bmc.2008.12.037 10.1093/jac/10.5.391 10.1016/j.lfs.2004.10.031 10.4103/0250-474X.45393 10.1124/jpet.110.174847 10.1158/1535-7163.MCT-11-0989 10.1158/1535-7163.MCT-13-0865 10.1093/jac/30.6.871 10.1021/jm00092a006 10.1016/j.ejmech.2015.04.015 10.1128/AAC.01217-06 10.1111/j.1538-7836.2008.03064.x 10.1159/000127837 10.7164/antibiotics.40.1468 10.1021/jm049486a 10.2174/1573406412666160920091146 10.1021/op900031h 10.1128/AAC.18.2.257 10.1021/acscentsci.0c01186 10.1111/bcp.13517 10.4103/0253-7613.111922 10.1039/b005804l 10.1159/000007106 10.1111/1346-8138.14607 10.1155/2018/4196961 10.1097/00006454-199803000-00022 10.1242/dmm.033860 10.1016/j.bmcl.2008.07.088 10.1128/AAC.01569-16 10.7164/antibiotics.33.783 10.1046/j.1365-2125.1997.00644.x 10.2174/1568026616666160506130731 10.1371/journal.pone.0101118 10.1128/AAC.00742-16 10.2165/00003495-198427060-00001 10.1002/jps.2600670944 10.1016/j.cbi.2016.07.024 10.1021/cc000002f 10.4049/jimmunol.152.5.2447 10.2165/00003495-200464220-00009 10.1124/jpet.106.115840 10.1007/s11095-015-1787-y 10.1128/MMBR.69.4.585-607.2005 10.1152/ajprenal.00454.2007 10.3892/ol.2017.6400 10.1016/S0002-9610(02)01125-X 10.1007/BF01273182 10.1002/ijc.29040 10.4155/fmc-2018-0196 10.1097/00006454-198710000-00034 10.5483/BMBRep.2016.49.4.220 10.7164/antibiotics.43.1047 10.1016/j.ijfoodmicro.2011.12.032 10.1002/bdrb.21165 10.1021/jm9607010 10.2174/1573406412666160201121310 10.1111/nmo.13813 10.1016/j.lfs.2007.01.035 10.1021/jm00362a014 10.1016/j.bmcl.2007.05.036 10.1007/s40265-015-0525-4 10.1002/(SICI)1521-4184(199910)332:10<343::AID-ARDP343>3.0.CO;2-0 10.1007/s00044-011-9685-2 10.1016/0223-5234(87)90169-3 10.1002/jlcr.2580330812 10.1007/s11307-022-01735-z 10.1016/j.lfs.2020.118119 10.1016/S0968-0896(03)00126-3 10.1021/jm00386a009 10.1128/AAC.35.10.2078 10.1007/s00044-008-9089-0 10.1128/AAC.01242-06 10.1186/s41936-020-00196-6 10.1016/0732-8893(95)00080-T 10.1111/j.1600-0609.2008.01198.x 10.1021/ml1000257 |
| ContentType | Journal Article |
| Copyright | 2023 Copyright © 2023. Published by Elsevier Masson SAS. |
| Copyright_xml | – notice: 2023 – notice: Copyright © 2023. Published by Elsevier Masson SAS. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.ejmech.2023.115172 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Chemistry Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1768-3254 |
| ExternalDocumentID | 36758304 10_1016_j_ejmech_2023_115172 S0223523423000879 |
| Genre | Journal Article Review |
| GroupedDBID | --- --K --M .~1 0R~ 1RT 1~. 1~5 4.4 457 4G. 5GY 5VS 7-5 71M 8P~ 9JM 9JN AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AARLI AATCM AAXUO ABFRF ABGSF ABJNI ABMAC ABOCM ABUDA ABYKQ ABZDS ACDAQ ACGFO ACIUM ACRLP ADBBV ADECG ADEZE ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AFZHZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJOXV AJSZI ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC CS3 DOVZS DU5 EBS EFJIC EFLBG EO8 EO9 EP2 EP3 F5P FDB FIRID FLBIZ FNPLU FYGXN G-Q GBLVA J1W KOM M2Y M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OZT P-8 P-9 P2P PC. Q38 ROL RPZ SCC SDF SDG SES SEW SPC SPCBC SSK SSP SSU SSZ T5K ~G- 1B1 29G 53G AAQXK AATTM AAXKI AAYOK AAYWO AAYXX ABFNM ABWVN ABXDB ACNNM ACRPL ACVFH ADCNI ADMUD ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRDE AGRNS AHHHB AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN BNPGV CITATION EJD FEDTE FGOYB G-2 HMS HMT HVGLF HZ~ IHE R2- RIG SCB SOC SPT SSH WUQ CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c428t-9e668c66a1bc8651bc2f442747221d0f7ace213b9d30e01c805c59d26008b4403 |
| IEDL.DBID | .~1 |
| ISSN | 0223-5234 1768-3254 |
| IngestDate | Fri Jul 11 13:10:04 EDT 2025 Wed Feb 19 02:25:12 EST 2025 Tue Jul 01 04:04:03 EDT 2025 Thu Apr 24 23:16:09 EDT 2025 Fri Feb 23 02:34:51 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Heterocycles Thiazole ring Chemical synthesis Clinical application Privileged scaffold |
| Language | English |
| License | Copyright © 2023. Published by Elsevier Masson SAS. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c428t-9e668c66a1bc8651bc2f442747221d0f7ace213b9d30e01c805c59d26008b4403 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0001-6771-9421 |
| PMID | 36758304 |
| PQID | 2775612798 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2775612798 pubmed_primary_36758304 crossref_citationtrail_10_1016_j_ejmech_2023_115172 crossref_primary_10_1016_j_ejmech_2023_115172 elsevier_sciencedirect_doi_10_1016_j_ejmech_2023_115172 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-03-15 |
| PublicationDateYYYYMMDD | 2023-03-15 |
| PublicationDate_xml | – month: 03 year: 2023 text: 2023-03-15 day: 15 |
| PublicationDecade | 2020 |
| PublicationPlace | France |
| PublicationPlace_xml | – name: France |
| PublicationTitle | European journal of medicinal chemistry |
| PublicationTitleAlternate | Eur J Med Chem |
| PublicationYear | 2023 |
| Publisher | Elsevier Masson SAS |
| Publisher_xml | – name: Elsevier Masson SAS |
| References | T. Takaya, H. Takasugi, T. Masugi, H. Yamanaka, K. Kawabata, 7-Acylamino-3-vinylcephalosporanic Acid Derivatives and Processes for the Preparation Thereof, US4409214A.. Schneider, Mierau (bib107) 1987; 30 H. Jianjin, L. Xiaojun, S. Bo, Y. Yan, Process for Producing 2-hydroxybenzamide Derivs, CN103709191A.. Richards, Heel, Brogden, Speight, Avery (bib35) 1984; 27 Jacqueline, Caillon, Le Mabecque, Miegeville, Hamel, Bugnon, Ge, Potel (bib63) 2007; 51 Woodfield, Van Rij, Pettigrew, van der Linden, Solomon, Bolt (bib26) 2003; 185 Greger, Eastman, Zhang, Bleam, Hughes, Smitheman, Dickerson, Laquerre, Liu, Gilmer (bib92) 2012; 11 Vengurlekar, Prachand, Jain, Gupta (bib14) 2014; 5 Wellington, Curran (bib60) 2004; 64 Andrabi, Ali, Tabassum, Parveen, Parvez (bib105) 2019; 12 Khames, Gad, Abd El-Raouf (bib142) 2017; 805 Kvernmo, Härtter, Burger (bib101) 2006; 28 Mezei, Mesterházy, Bakó, Porcs-Makkay, Simig, Volk (bib137) 2009; 13 Karade, Acharya, Sathe, Kaushik (bib11) 2008; 17 Y. Kumar, M. Prasad, A. Prasad, S.K. Singh, N.P. Kumar, Preparation of Crystalline Cefdinir Potassium Dihydrate, WO2003050124A1.. Standridge, Swigor (bib56) 1993; 33 Rajagopalan, Pan, Schaefer, Nicholas, Lim, Misialek, Stevens, Hooi, Aleskovski, Ruhrmund (bib76) 2017; 61 Fukushima‐Shintani, Suzuki, Iwatsuki, Abe, Sugasawa, Hirayama, Kawasaki, Nakahata (bib128) 2009; 82 Gurupadayya, Gopal, Padmashali, Manohara (bib6) 2008; 70 Jang, Choi, Kim, Kim, Kang, Park, Ryu, Lee, Kim, Rhee (bib23) 2014; 9 Yoshii, Iikura, Hirayama, Toda, Kawabata (bib117) 2016; 33 Fikry, Hasan, Mohamed (bib136) 2018; 32 Jubie, Gowramma, Nitin, Jawahar, Kalirajan, Gomathy, Sankar, Elango (bib17) 2009; 1 Reiner, Weiss, Brombacher, Lanz, Montavon, Furlenmeier, Angehrn, Probst (bib36) 1980; 32 Ito, Sato, Ota, Takemura, Nishikawa, Toba, Kohira, Miyagawa, Ishibashi, Matsumoto (bib65) 2018; 62 M. Soukup, Process for the Manufacture of Enantiomerically Pure Antifungal Azoles as Ravuconazole and Isavuconazole, US8207352B2.. Ayati, Emami, Asadipour, Shafiee, Foroumadi (bib18) 2015; 97 Benedetti, Norbedo (bib83) 2001 Sánchez-Lozada, Tapia, Bautista-García, Soto, Ávila-Casado, Vega-Campos, Nakagawa, Zhao, Franco, Johnson (bib139) 2008; 294 Van, Nguyen, Smooker, Coloe (bib24) 2012; 154 Rossignol, La Frazia, Chiappa, Ciucci, Santoro (bib85) 2009; 284 W.E. Klunk, C.A.M. Jr, Amyloid Imaging as a Surrofate Marker for Efficacy of Anti-amyloid Therapies, US8147798B2.. Nagata, Yoshino, Haginoya, Yoshikawa, Nagamochi, Kobayashi, Komoriya, Yokomizo, Muto, Yamaguchi, Osanai, Suzuki, Kanno (bib125) 2009; 17 Pattan, Dighe, Nirmal, Merekar, Laware, Shinde, Musmade (bib12) 2009; 2 Raboisson, de Kock, Rosenquist, Nilsson, Salvador-Oden, Lin, Roue, Ivanov, Wahling, Wickstrom, Hamelink, Edlund, Vrang, Vendeville, Van de Vreken, McGowan, Tahri, Hu, Boutton, Lenz, Delouvroy, Pille, Surleraux, Wigerinck, Samuelsson, Simmen (bib77) 2008; 18 Z Laczkowski, Biernasiuk, Baranowska-Laczkowska, Misiura, Malm, Plech, Paneth (bib9) 2016; 12 Hakimizadeh, Hassanshahi, Kaeidi, Nematollahi, Taghipour, Rahmani, Fatemi (bib30) 2020; 258 Foye (bib31) 2008 Okura, Ito, Ishiguro, Tamai, Deguchi (bib102) 2007; 80 Hantzsch, Weber (bib2) 1887; 20 Scheffers, Pinho (bib32) 2005; 69 Ishikawa, Matsunaga, Tawada, Kuroda, Nakayama, Ishibashi, Tomimoto, Ikeda, Tagawa, Iizawa (bib64) 2003; 11 Raboisson, de Kock, Rosenquist, Nilsson, Salvador-Oden, Lin, Roue, Ivanov, Wähling, Wickström (bib74) 2008; 18 Kim (bib126) 2016; 76 Matsunaga, Tanaka, Yoshinaga, Ueki, Hori, Eta, Kawabata, Yoshii, Yoshida, Matsumura (bib115) 2011; 336 M. Numata, I. Mimamida, M. Yamaoka, M. Shiraishi, Toshio Miyawaki, Cephalosporin Derivatives, US4421912. Carvey, Pieri, Ling (bib104) 1997; 104 Lazer, Miao, Cywin, Sorcek, Wong, Meng, Potocki, Hoermann, Snow, Tschantz (bib134) 1997; 40 R.B. Sykes, W.L. Parker, C.M. Cimarusti, W.H. Koster, W.A. Slusarchyk, 2-Oxo-1-azetidinesulfonic Acid Salts, US4775670A.. M. Nagasawa, M. Murata, H. Nishioka, T. Kurimoto, S. Ueki, O. Kitagawa, Preparation of Aminothiazole Derivatives as Ameliorating Agents for Digestive Tract Movements, WO9636619A1.. M. Takayama, N. Kurose, Pharmaceutical Composition Containing Optically Active Compound Having Thrombopoietin Receptor Agonist Activity and Intermediate Thereof, WO2009017098A1.. Petrou, Fesatidou, Geronikaki (bib3) 2021; 26 Labro, El Benna, Charlier, Abdelghaffar, Hakim (bib57) 1994; 152 Koufaki, Kiziridi, Nikoloudaki, Alexis (bib16) 2007; 17 Falci, Pasqualotto (bib69) 2013; 6 Hamashima, Kubota, Minami, Ishikura, Konoike, Yoshioka, Yoshida, Nakashimizu, Motokawa (bib53) 1987; 40 R. Heymes, A. Lutz, 3-Acetoxymethyl-7-(hydroxyiminoacetamido)-cephalosporanic Acid Derivatives, US4283396A. Mishra, Kumari, Tiwari (bib21) 2015; 92 Collo, Cavalleri, Bono, Mora, Fedele, Invernizzi, Gennarelli, Piovani, Kunath, Millan (bib103) 2018; 2018 Scholz, Hofmann, Noack, Edwards, Stoeckel (bib25) 1998; 44 Simmons, Gelfand, Grogan, Craft (bib27) 1995; 22 Lombardo, Lee, Chen, Norris, Barrish, Behnia, Castaneda, Cornelius, Das, Doweyko (bib89) 2004; 47 R.P. Pioch Kashyap, Garg, Sharma, Kumar, Dudhe, Gupta (bib20) 2012; 21 Sur, Adamczuk, Scott, Kost, Sampat, Buckley, Farrar, Newton, Suhy, Bennacef (bib108) 2022; 24 Yamawaki, Futagami, Sakasegawa, Murakami, Agawa, Ikeda, Noda, Kirita, Gudis, Higuchi (bib116) 2020; 32 Iwahi, Tsuchiya (bib41) 1980; 18 Gobin, Huin, Lamoureux, Ory, Charrier, Lanel, Battaglia, Redini, Lezot, Blanchard (bib99) 2015; 136 Muhammad, S Masaret, M Amin, Abdallah, Farghaly (bib8) 2017; 13 Takano, Hase-Aoki, Horiuchi, Zhao, Kasahara, Kondo, Becker (bib138) 2005; 76 U. Yasutsugu, M.J. D, G. Jerzy, H.T. W, C. Chung-Pin, Process for Preparation of Water Soluble Azole Compounds, WO0152852A1.. Y. Nishitani, Cephalosporin Having Catechol Group, WO2010050468A1.. Weichold, Bryant, Pati, Barabitskaya, Gallo, Reitz (bib80) 1999; 2 Posobiec, Vidal, Hughes‐Earle, Laffan, Hart (bib95) 2015; 104 M.V. Thippannachar, D.D. Gulabrao, V.S. Popat, A Process for Preparation of Mirabegron and Alpha Cryatalline Form Thereof, WO2015044965A1.. Hunt (bib87) 2009; 8 Gudnason, Gudbrandsson, Barsanti, Kristinsson (bib34) 1998; 17 Gobeaux, Ambart, Couderc, Renard, De Charnace, Lokiec (bib33) 1989; 73 Gümüş, Yakan, Koca (bib19) 2019; 11 thiazolylmethylthloalkyl- Sun, Ye, Liang, Liu, Li, Lu, Huang, Zhao, Tan, Lai (bib79) 2021; 6 Lin, Evans, Warrick, Pioch (bib111) 1986; 239 Li, Ghoshal, Arora, Erstad, Sojoodi, Lanuti, Hoshida, Baumert, Tanabe, Fuchs (bib112) 2018; 78 Drewe, Gutmann, Fricker, Török, Beglinger, Huwyler (bib81) 1999; 57 Parish, Scheinfeld (bib62) 2008; 9 Ergenç, Çapan, Günay, Özkirimli, Güngör, Özbey, Kendi (bib15) 1999; 332 K. Fujimoto, E. Nakayama, H. Nakao, Process for Preparing 3-alkoxymethylcephalosporin Derivatives, US4482710.. Guay, Koskoletos (bib38) 1985; 4 Z. Matej, G. Stanislav, A. Borut, Z. Rok, K. Ivanka, Novel Process for Synthesis of Pramipexole and its Pharmaceutically Acceptable Salts, WO2008097203A1.. Donnelley, Zhu, Thompson (bib67) 2016; 9 B. Erb, I.S. Gallou, F.K. Kleinbeck, Synthesis of 2-carboxamide Cycloamino Urea Derivatives, US20130331579A1.. Kearns, Reed, Jacobs, Ardite, Yogev, Blumer (bib52) 1991; 35 Takasu, Ukai, Sato, Matsui, Nagase, Maruyama, Sasamata, Miyata, Uchida, Yamaguchi (bib132) 2007; 321 Nomoto, Zamora, Schuck, Boyd, Chang, Aluri, Siu, Lai, Yasuda, Ferry (bib130) 2018; 84 Kobayashi, Uchida, Kawakami (bib37) 1992; 30 M. Gharpure, S. Deshmukh, R. Mahale, Process for the Manufacture of Cefpodoxime Proxetil, US10541473.. Hara, Sato, Miyagishi, Aisaka, Hibino (bib122) 1978; 67 Bishayee, Karmakar, Mandal, Kundu, Chatterjee (bib5) 1997 McLeod, Nahata, Barson (bib29) 1985; 19 Furet, Guagnano, Fairhurst, Imbach-Weese, Bruce, Knapp, Fritsch, Blasco, Blanz, Aichholz (bib97) 2013; 23 Hargrave, Hess, Oliver (bib7) 1983; 26 H. Axel, G. Joel, Antitumor Combination of B-Raf, MEK, and EGFR inhibitors, WO2014066606A2.. Iturriaga, Paredes, Arias, Torres (bib135) 2017; 14 Zhou, Hong, Zhang, Chen, Han, Shen, Zhu, Gao (bib120) 2014; 9 Jung, Kang, Lee, Noh, Kim, Han, Baek, Kim, Bae (bib94) 2016; 49 Steinmann, Dittmer, Houbraken, Buer, Rath (bib68) 2016; 60 Watanabe, Tsubouchi, Okubo (bib72) 2018; 45 Fritsch, Huang, Chatenay-Rivauday, Schnell, Reddy, Liu, Kauffmann, Guthy, Erdmann, De Pover (bib98) 2014; 13 Sánchez-Lozada, Tapia, Soto, Ávila-Casado, Franco, Wessale, Zhao, Johnson (bib140) 2008; 108 X. He, L. Du, J. Zhu, Y. Wang, Method for Preparation of Febuxostat, WO2011082623A1.. Patt, Hamilton, Taylor, Ryan, Taylor, Connolly, Doherty, Klutchko, Sircar (bib10) 1992; 35 K. Sugasawa, S. Watanuki, Y. Koga, H. Nagata, K. Obitsu, R. Wakayama, F. Hirayama, K.-i. Suzuki, Preparation of 2-acylaminothiazole Derivatives or Salts Thereof as C-Mpl Receptor Ligands, WO2003062233A1.. Andreani, Rambaldi, Mascellani, Rugarli (bib13) 1987; 22 T Chhabria, Patel, Modi, S Brahmkshatriya, Thiazole (bib22) 2016; 16 W. Yong, W. Jian, D. Zexin, Y. Guiju, C. Xuejiao, J. Xiaojun, Method for Preparing Nitazoxanide, CN103159697A.. A.E. Storey, C.L. Jones, D.R.C. Bouvet, N. Lasbistes, S.M. Fairway, L. Williams, A.M. Gibson, R.J. Nairne, F. Karimi, B. Langstrom, Fluorination Process of Anilide Derivatives and Benzothiazole Fluorinate Derivatives as Werner, Heizmann, Höflsauer (bib48) 1991; 19 J. Lajeunesse, J.D. DiMarco, M. Galella, R. Chidambaram, Process for Preparing 2-Aminothiazole-5-Aromatic Carboxamides as Kinase Inhibitors, US8242270B2.. Neu (bib45) 1987; 6 G.D. Vite, R.M. Borzilleri, S.-h. Kim, J.A. Johnson, Epothilone Derivatives, WO9902514A2.. Xu, Cai (bib129) 2019; 12 Cafini, Yuste, Giménez, Sevillano, Aguilar, Alou, Ramos-Sevillano, Torrico, González, García (bib59) 2010; 5 Xu, Liu, Murray, Callebaut, Lee, Hong, Strickley, Tsai, Stray, Wang (bib84) 2010; 1 Y. Kumar, N. Tewari, R. Aryan, B. Rai, H. Nizar, Process for the Preparation of Cefpodoxime Acid, US20050020561A1.. Imaging Agents, WO2007020400A1.. Alazzouni, Abdel Aziz, Elnabtity, Salem (bib113) 2020; 81 alkylamidines and Ralated Compounds, US4375547.. Tsuchihashi, Nakashima, Kinami, Nagatomo (bib121) 1990; 52 S. Tsushima, M. Sendai, M. Shiraishi, Novel 3-Acyloxymethyl-Cephem Co Standridge (10.1016/j.ejmech.2023.115172_bib56) 1993; 33 T Chhabria (10.1016/j.ejmech.2023.115172_bib22) 2016; 16 Guay (10.1016/j.ejmech.2023.115172_bib38) 1985; 4 Patt (10.1016/j.ejmech.2023.115172_bib10) 1992; 35 10.1016/j.ejmech.2023.115172_bib71 10.1016/j.ejmech.2023.115172_bib73 Alazzouni (10.1016/j.ejmech.2023.115172_bib113) 2020; 81 Fikry (10.1016/j.ejmech.2023.115172_bib136) 2018; 32 Petrou (10.1016/j.ejmech.2023.115172_bib3) 2021; 26 Lombardo (10.1016/j.ejmech.2023.115172_bib89) 2004; 47 Rossignol (10.1016/j.ejmech.2023.115172_bib85) 2009; 284 Gümüş (10.1016/j.ejmech.2023.115172_bib19) 2019; 11 Yamawaki (10.1016/j.ejmech.2023.115172_bib116) 2020; 32 Eagling (10.1016/j.ejmech.2023.115172_bib78) 1997; 44 Takasu (10.1016/j.ejmech.2023.115172_bib132) 2007; 321 Mishra (10.1016/j.ejmech.2023.115172_bib21) 2015; 92 Scheffers (10.1016/j.ejmech.2023.115172_bib32) 2005; 69 Matsunaga (10.1016/j.ejmech.2023.115172_bib115) 2011; 336 Fukushima‐Shintani (10.1016/j.ejmech.2023.115172_bib128) 2009; 82 Fritsch (10.1016/j.ejmech.2023.115172_bib98) 2014; 13 Koufaki (10.1016/j.ejmech.2023.115172_bib16) 2007; 17 Seifert (10.1016/j.ejmech.2023.115172_bib70) 2007; 51 Yahav (10.1016/j.ejmech.2023.115172_bib54) 2007; 7 Gobeaux (10.1016/j.ejmech.2023.115172_bib33) 1989; 73 Xu (10.1016/j.ejmech.2023.115172_bib84) 2010; 1 Richards (10.1016/j.ejmech.2023.115172_bib35) 1984; 27 Watt (10.1016/j.ejmech.2023.115172_bib42) 1982; 10 10.1016/j.ejmech.2023.115172_bib82 Ergenç (10.1016/j.ejmech.2023.115172_bib15) 1999; 332 10.1016/j.ejmech.2023.115172_bib86 Parish (10.1016/j.ejmech.2023.115172_bib62) 2008; 9 Sakagami (10.1016/j.ejmech.2023.115172_bib61) 1990; 43 10.1016/j.ejmech.2023.115172_bib88 Collo (10.1016/j.ejmech.2023.115172_bib103) 2018; 2018 10.1016/j.ejmech.2023.115172_bib127 Carvey (10.1016/j.ejmech.2023.115172_bib104) 1997; 104 Kobayashi (10.1016/j.ejmech.2023.115172_bib37) 1992; 30 Wellington (10.1016/j.ejmech.2023.115172_bib60) 2004; 64 Hara (10.1016/j.ejmech.2023.115172_bib122) 1978; 67 Sánchez-Lozada (10.1016/j.ejmech.2023.115172_bib140) 2008; 108 Schneider (10.1016/j.ejmech.2023.115172_bib107) 1987; 30 Furugohri (10.1016/j.ejmech.2023.115172_bib123) 2008; 6 Woodfield (10.1016/j.ejmech.2023.115172_bib26) 2003; 185 Bishayee (10.1016/j.ejmech.2023.115172_bib5) 1997 Sur (10.1016/j.ejmech.2023.115172_bib108) 2022; 24 Yoshii (10.1016/j.ejmech.2023.115172_bib117) 2016; 33 10.1016/j.ejmech.2023.115172_bib50 10.1016/j.ejmech.2023.115172_bib51 Andrabi (10.1016/j.ejmech.2023.115172_bib105) 2019; 12 Sun (10.1016/j.ejmech.2023.115172_bib79) 2021; 6 Gobin (10.1016/j.ejmech.2023.115172_bib99) 2015; 136 10.1016/j.ejmech.2023.115172_bib58 Furet (10.1016/j.ejmech.2023.115172_bib97) 2013; 23 10.1016/j.ejmech.2023.115172_bib131 Lazer (10.1016/j.ejmech.2023.115172_bib134) 1997; 40 10.1016/j.ejmech.2023.115172_bib133 Kashyap (10.1016/j.ejmech.2023.115172_bib20) 2012; 21 Muhammad (10.1016/j.ejmech.2023.115172_bib8) 2017; 13 Hamashima (10.1016/j.ejmech.2023.115172_bib53) 1987; 40 Arshad (10.1016/j.ejmech.2023.115172_bib4) 2022; 27 Nomoto (10.1016/j.ejmech.2023.115172_bib130) 2018; 84 Donnelley (10.1016/j.ejmech.2023.115172_bib67) 2016; 9 Kearns (10.1016/j.ejmech.2023.115172_bib52) 1991; 35 Pattan (10.1016/j.ejmech.2023.115172_bib12) 2009; 2 Cafini (10.1016/j.ejmech.2023.115172_bib59) 2010; 5 Kvernmo (10.1016/j.ejmech.2023.115172_bib101) 2006; 28 Gudnason (10.1016/j.ejmech.2023.115172_bib34) 1998; 17 Benedetti (10.1016/j.ejmech.2023.115172_bib83) 2001 Falci (10.1016/j.ejmech.2023.115172_bib69) 2013; 6 10.1016/j.ejmech.2023.115172_bib66 Ishikawa (10.1016/j.ejmech.2023.115172_bib64) 2003; 11 Lee (10.1016/j.ejmech.2023.115172_bib93) 2016; 256 Khames (10.1016/j.ejmech.2023.115172_bib142) 2017; 805 10.1016/j.ejmech.2023.115172_bib143 McLeod (10.1016/j.ejmech.2023.115172_bib29) 1985; 19 Jacqueline (10.1016/j.ejmech.2023.115172_bib63) 2007; 51 10.1016/j.ejmech.2023.115172_bib109 Ito (10.1016/j.ejmech.2023.115172_bib65) 2018; 62 Lin (10.1016/j.ejmech.2023.115172_bib111) 1986; 239 10.1016/j.ejmech.2023.115172_bib106 Raboisson (10.1016/j.ejmech.2023.115172_bib77) 2008; 18 Jubie (10.1016/j.ejmech.2023.115172_bib17) 2009; 1 Mezei (10.1016/j.ejmech.2023.115172_bib137) 2009; 13 Gurupadayya (10.1016/j.ejmech.2023.115172_bib6) 2008; 70 Posobiec (10.1016/j.ejmech.2023.115172_bib95) 2015; 104 Ganellin (10.1016/j.ejmech.2023.115172_bib40) 2010 Hargrave (10.1016/j.ejmech.2023.115172_bib7) 1983; 26 10.1016/j.ejmech.2023.115172_bib114 Andreani (10.1016/j.ejmech.2023.115172_bib13) 1987; 22 10.1016/j.ejmech.2023.115172_bib39 Simmons (10.1016/j.ejmech.2023.115172_bib27) 1995; 22 Watanabe (10.1016/j.ejmech.2023.115172_bib72) 2018; 45 10.1016/j.ejmech.2023.115172_bib110 Drewe (10.1016/j.ejmech.2023.115172_bib81) 1999; 57 Karade (10.1016/j.ejmech.2023.115172_bib11) 2008; 17 Iturriaga (10.1016/j.ejmech.2023.115172_bib135) 2017; 14 Menzies (10.1016/j.ejmech.2023.115172_bib91) 2012; 6 10.1016/j.ejmech.2023.115172_bib118 10.1016/j.ejmech.2023.115172_bib119 Franzén (10.1016/j.ejmech.2023.115172_bib1) 2000; 2 Jung (10.1016/j.ejmech.2023.115172_bib94) 2016; 49 Labro (10.1016/j.ejmech.2023.115172_bib57) 1994; 152 Hunt (10.1016/j.ejmech.2023.115172_bib87) 2009; 8 10.1016/j.ejmech.2023.115172_bib43 10.1016/j.ejmech.2023.115172_bib44 Vengurlekar (10.1016/j.ejmech.2023.115172_bib14) 2014; 5 10.1016/j.ejmech.2023.115172_bib47 10.1016/j.ejmech.2023.115172_bib124 Okura (10.1016/j.ejmech.2023.115172_bib102) 2007; 80 10.1016/j.ejmech.2023.115172_bib49 Greger (10.1016/j.ejmech.2023.115172_bib92) 2012; 11 Iwahi (10.1016/j.ejmech.2023.115172_bib41) 1980; 18 Tsuchihashi (10.1016/j.ejmech.2023.115172_bib121) 1990; 52 Xu (10.1016/j.ejmech.2023.115172_bib129) 2019; 12 Jang (10.1016/j.ejmech.2023.115172_bib23) 2014; 9 Hakimizadeh (10.1016/j.ejmech.2023.115172_bib30) 2020; 258 Weichold (10.1016/j.ejmech.2023.115172_bib80) 1999; 2 Li (10.1016/j.ejmech.2023.115172_bib112) 2018; 78 10.1016/j.ejmech.2023.115172_bib90 Foye (10.1016/j.ejmech.2023.115172_bib31) 2008 10.1016/j.ejmech.2023.115172_bib96 Kim (10.1016/j.ejmech.2023.115172_bib126) 2016; 76 Karve (10.1016/j.ejmech.2023.115172_bib141) 2013; 45 Hantzsch (10.1016/j.ejmech.2023.115172_bib2) 1887; 20 Werner (10.1016/j.ejmech.2023.115172_bib48) 1991; 19 Rajagopalan (10.1016/j.ejmech.2023.115172_bib76) 2017; 61 Chapman (10.1016/j.ejmech.2023.115172_bib55) 2003; 2 Z Laczkowski (10.1016/j.ejmech.2023.115172_bib9) 2016; 12 Nagata (10.1016/j.ejmech.2023.115172_bib125) 2009; 17 Sánchez-Lozada (10.1016/j.ejmech.2023.115172_bib139) 2008; 294 Lo (10.1016/j.ejmech.2023.115172_bib75) 2021; 7 Reiner (10.1016/j.ejmech.2023.115172_bib36) 1980; 32 Ayati (10.1016/j.ejmech.2023.115172_bib18) 2015; 97 Takano (10.1016/j.ejmech.2023.115172_bib138) 2005; 76 Zhou (10.1016/j.ejmech.2023.115172_bib120) 2014; 9 Steinmann (10.1016/j.ejmech.2023.115172_bib68) 2016; 60 Scholz (10.1016/j.ejmech.2023.115172_bib25) 1998; 44 Unemo (10.1016/j.ejmech.2023.115172_bib46) 2012; 56 10.1016/j.ejmech.2023.115172_bib28 Raboisson (10.1016/j.ejmech.2023.115172_bib74) 2008; 18 Van (10.1016/j.ejmech.2023.115172_bib24) 2012; 154 Neu (10.1016/j.ejmech.2023.115172_bib45) 1987; 6 10.1016/j.ejmech.2023.115172_bib100 |
| References_xml | – volume: 13 start-page: 1117 year: 2014 end-page: 1129 ident: bib98 article-title: Characterization of the novel and specific PI3Kα inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trialsNVP-BYL719 PI3Kα inhibitor and predictive response modeling publication-title: Mol. Cancer Therapeut. – volume: 17 start-page: 258 year: 1998 end-page: 260 ident: bib34 article-title: Penetration of ceftriaxone into the middle ear fluid of children publication-title: Pediatr. Infect. Dis. J. – volume: 6 start-page: 1 year: 2021 end-page: 3 ident: bib79 article-title: Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease publication-title: Signal Transduct. Tar. – volume: 1 start-page: 209 year: 2010 end-page: 213 ident: bib84 article-title: Cobicistat (GS-9350): a potent and selective inhibitor of human CYP3A as a novel pharmacoenhancer publication-title: ACS Med. Chem. Lett. – volume: 19 start-page: 377 year: 1991 end-page: 379 ident: bib48 article-title: Comparative publication-title: Infection – year: 2010 ident: bib40 article-title: Analogue-based Drug Discovery II – volume: 7 start-page: 338 year: 2007 end-page: 348 ident: bib54 article-title: Efficacy and safety of cefepime: a systematic review and meta-analysis publication-title: Lancet Infect. Dis. – reference: R. Heymes, A. Lutz, 3-Acetoxymethyl-7-(hydroxyiminoacetamido)-cephalosporanic Acid Derivatives, US4283396A. – reference: A.E. Storey, C.L. Jones, D.R.C. Bouvet, N. Lasbistes, S.M. Fairway, L. Williams, A.M. Gibson, R.J. Nairne, F. Karimi, B. Langstrom, Fluorination Process of Anilide Derivatives and Benzothiazole Fluorinate Derivatives as – volume: 26 start-page: 1158 year: 1983 end-page: 1163 ident: bib7 article-title: -(4-Substituted-thiazolyl) oxamic acid derivatives, new series of potent, orally active antiallergy agents publication-title: J. Med. Chem. – volume: 23 start-page: 3741 year: 2013 end-page: 3748 ident: bib97 article-title: Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation publication-title: Bioorg. Med. Chem. Lett. – reference: H. Jianjin, L. Xiaojun, S. Bo, Y. Yan, Process for Producing 2-hydroxybenzamide Derivs, CN103709191A.. – volume: 9 start-page: 201 year: 2008 end-page: 209 ident: bib62 article-title: Ceftaroline fosamil, a cephalosporin derivative for the potential treatment of MRSA infection publication-title: Curr. Opin. Invest. Drugs – volume: 81 start-page: 1 year: 2020 end-page: 13 ident: bib113 article-title: Comparative histological and histochemical studies between ranitidine and nizatidine in treatment of peptic ulcer with evaluation of their adverse effects on male sex hormones publication-title: J. Basic Appl. Zool. – volume: 67 start-page: 1334 year: 1978 end-page: 1335 ident: bib122 article-title: Synthesis and β-adrenergic blocking action of a new thiazolylthiopropanolamine derivative publication-title: J. Pharmacol. Sci. – volume: 805 start-page: 118 year: 2017 end-page: 124 ident: bib142 article-title: Ameliorative effects of sildenafil and/or febuxostat on doxorubicin-induced nephrotoxicity in rats publication-title: Eur. J. Pharmacol. – volume: 64 start-page: 2597 year: 2004 end-page: 2618 ident: bib60 publication-title: Cefditoren Pivoxil, Drugs – volume: 321 start-page: 642 year: 2007 end-page: 647 ident: bib132 article-title: Effect of ( publication-title: J. Pharmacol. Exp. Therapeut. – volume: 17 start-page: 4223 year: 2007 end-page: 4227 ident: bib16 article-title: Design and synthesis of 1, 2-dithiolane derivatives and evaluation of their neuroprotective activity publication-title: Bioorg. Med. Chem. Lett. – start-page: 58 year: 1997 end-page: 70 ident: bib5 article-title: Vanadium-mediated chemoprotection against chemical hepatocarcinogenesis in rats: haematological and histological characteristics publication-title: Eur. J. Cancer Prev. – volume: 284 start-page: 29798 year: 2009 end-page: 29808 ident: bib85 article-title: Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level publication-title: J. Biol. Chem. – volume: 2 start-page: 196 year: 2009 end-page: 201 ident: bib12 article-title: Synthesis and biological evaluation of some substituted amino thiazole derivatives publication-title: Asian J. Res. Chem. – volume: 45 start-page: 1151 year: 2018 end-page: 1159 ident: bib72 article-title: Efficacy and safety of fosravuconazole L‐lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: a multicenter, double‐blind, randomized phase III study publication-title: J. Dermatol. – volume: 32 year: 2018 ident: bib136 article-title: Rutin and meloxicam attenuate paw inflammation in mice: affecting sorbitol dehydrogenase activity publication-title: J. Biochem. Mol. Toxicol. – reference: M. Gharpure, S. Deshmukh, R. Mahale, Process for the Manufacture of Cefpodoxime Proxetil, US10541473.. – volume: 92 start-page: 1 year: 2015 end-page: 34 ident: bib21 article-title: Thiazole: a promising heterocycle for the development of potent CNS active agents publication-title: Eur. J. Med. Chem. – reference: W.E. Klunk, C.A.M. Jr, Amyloid Imaging as a Surrofate Marker for Efficacy of Anti-amyloid Therapies, US8147798B2.. – reference: S. Tsushima, M. Sendai, M. Shiraishi, Novel 3-Acyloxymethyl-Cephem Compounds Useful as Intermediates for Preparing Cephalosporin Antibiotics, US4245088A.. – volume: 2018 start-page: 4196961 year: 2018 ident: bib103 article-title: Ropinirole and pramipexole promote structural plasticity in human iPSC-derived dopaminergic neurons via BDNF and mTOR signaling publication-title: Neural Plast – volume: 8 start-page: 275 year: 2009 end-page: 281 ident: bib87 article-title: Discovery of ixabepilone publication-title: Mol. Cancer Therapeut. – reference: '-alkylamidines and Ralated Compounds, US4375547.. – volume: 22 start-page: 155 year: 1995 end-page: 157 ident: bib27 article-title: Cefotaxime twice daily versus ceftriaxone once daily: a randomized controlled study in patients with serious infections, Diagn publication-title: Microorg. Infect. Dis. – volume: 26 start-page: 3166 year: 2021 ident: bib3 article-title: Thiazole ring-a biologically active scaffold publication-title: Molecules – volume: 9 start-page: 79 year: 2016 end-page: 86 ident: bib67 article-title: Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections publication-title: Infect. Drug Resist. – volume: 14 start-page: 2198 year: 2017 end-page: 2206 ident: bib135 article-title: Meloxicam decreases the migration and invasion of CF41. Mg canine mammary carcinoma cells publication-title: Oncol. Lett. – volume: 69 start-page: 585 year: 2005 end-page: 607 ident: bib32 article-title: Bacterial cell wall synthesis: new insights from localization studies publication-title: Microbiol. Mol. Biol. Rev. – volume: 11 start-page: 2427 year: 2003 end-page: 2437 ident: bib64 article-title: TAK-599, a novel publication-title: Bioorg. Med. Chem. – reference: L. Al-Razzak, D. Kaul, L.P. Manning, K.C. Marsh, Pharmaceutical Compositions Containing HIV Protease Inhibitors, AU700942B2.. – volume: 32 year: 2020 ident: bib116 article-title: Acotiamide attenuates central urocortin 2‐induced intestinal inflammatory responses, and urocortin 2 treatment reduces TNF‐α productions in LPS‐stimulated macrophage cell lines publication-title: Neurogastroent. Motil. – volume: 2 start-page: 195 year: 2000 end-page: 214 ident: bib1 article-title: Recent advances in the preparation of heterocycles on solid support: a review of the literature publication-title: J. Comb. Chem. – volume: 24 start-page: 862 year: 2022 end-page: 873 ident: bib108 article-title: Evaluation of publication-title: Mol. Imag. Biol. – volume: 33 start-page: 292 year: 2016 end-page: 300 ident: bib117 article-title: Physiologically-based pharmacokinetic and pharmacodynamic modeling for the inhibition of acetylcholinesterase by acotiamide, a novel gastroprokinetic agent for the treatment of functional dyspepsia, in rat stomach publication-title: Pharm. Res. (N. Y.) – volume: 45 start-page: 244 year: 2013 end-page: 247 ident: bib141 article-title: Evaluation of effect of allopurinol and febuxostat in behavioral model of depression in mice publication-title: Indian J. Pharmacol. – volume: 61 year: 2017 ident: bib76 article-title: Preclinical characterization and human microdose pharmacokinetics of ITMN-8187, a nonmacrocyclic inhibitor of the hepatitis C virus NS3 protease publication-title: Antimicrob. Agents Chemother. – reference: J. Lajeunesse, J.D. DiMarco, M. Galella, R. Chidambaram, Process for Preparing 2-Aminothiazole-5-Aromatic Carboxamides as Kinase Inhibitors, US8242270B2.. – volume: 76 start-page: 1835 year: 2005 end-page: 1847 ident: bib138 article-title: Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase publication-title: Life Sci. – volume: 44 start-page: 190 year: 1997 end-page: 194 ident: bib78 article-title: Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir, Brit publication-title: J. Clin. Pharmacol. – volume: 6 start-page: 1542 year: 2008 end-page: 1549 ident: bib123 article-title: DU‐176b, a potent and orally active factor Xa inhibitor: publication-title: J. Thromb. Haemostasis – volume: 6 start-page: 163 year: 2013 end-page: 174 ident: bib69 article-title: Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections publication-title: Infect. Drug Resist. – volume: 57 start-page: 1147 year: 1999 end-page: 1152 ident: bib81 article-title: HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833 publication-title: Biochem. Pharmacol. – reference: -thiazolylmethylthloalkyl- – reference: K. Sugasawa, S. Watanuki, Y. Koga, H. Nagata, K. Obitsu, R. Wakayama, F. Hirayama, K.-i. Suzuki, Preparation of 2-acylaminothiazole Derivatives or Salts Thereof as C-Mpl Receptor Ligands, WO2003062233A1.. – reference: K. Fujimoto, E. Nakayama, H. Nakao, Process for Preparing 3-alkoxymethylcephalosporin Derivatives, US4482710.. – volume: 73 start-page: 574 year: 1989 end-page: 575 ident: bib33 article-title: Ceftriaxone diffusion from blood to aqueous humour in man publication-title: Br. J. Ophthalmol. – volume: 256 start-page: 266 year: 2016 end-page: 273 ident: bib93 article-title: Anti-inflammatory effects of dabrafenib on polyphosphate-mediated vascular disruption publication-title: Chem. Biol. Interact. – volume: 30 start-page: 871 year: 1992 end-page: 872 ident: bib37 article-title: Synergy with aztreonam and arbekacin or tobramycin against Pseudomonas aeruginosa from blood publication-title: J. Antimicrob. Chemother. – reference: M. Soukup, Process for the Manufacture of Enantiomerically Pure Antifungal Azoles as Ravuconazole and Isavuconazole, US8207352B2.. – volume: 18 start-page: 4853 year: 2008 end-page: 4858 ident: bib74 article-title: Structure-activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350 publication-title: Bioorg. Med. Chem. Lett. – volume: 11 start-page: 1979 year: 2019 end-page: 1998 ident: bib19 article-title: Recent advances of thiazole hybrids in biological applications publication-title: Future Med. Chem. – volume: 17 start-page: 1193 year: 2009 end-page: 1206 ident: bib125 article-title: Discovery of publication-title: Bioorg. Med. Chem. – volume: 44 start-page: 142 year: 1998 end-page: 147 ident: bib25 article-title: Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children publication-title: Chemotherapy – year: 2008 ident: bib31 article-title: Foye's Principles of Medicinal Chemistry – volume: 17 start-page: 19 year: 2008 end-page: 29 ident: bib11 article-title: Design, synthesis, and antimalarial evaluation of thiazole-derived amino acids publication-title: Med. Chem. Res. – reference: B. Erb, I.S. Gallou, F.K. Kleinbeck, Synthesis of 2-carboxamide Cycloamino Urea Derivatives, US20130331579A1.. – reference: Imaging Agents, WO2007020400A1.. – volume: 18 start-page: 4853 year: 2008 end-page: 4858 ident: bib77 article-title: Structure-activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350 publication-title: Bioorg. Med. Chem. Lett. – reference: M. Nagasawa, M. Murata, H. Nishioka, T. Kurimoto, S. Ueki, O. Kitagawa, Preparation of Aminothiazole Derivatives as Ameliorating Agents for Digestive Tract Movements, WO9636619A1.. – volume: 7 start-page: 792 year: 2021 end-page: 802 ident: bib75 article-title: Simeprevir potently suppresses SARS-CoV-2 replication and synergizes with remdesivir publication-title: ACS Cent. Sci. – volume: 20 start-page: 3118 year: 1887 end-page: 3132 ident: bib2 article-title: Ueber verbindungen des thiazols (pyridins der thiophenreihe) publication-title: Eur. J. Inorg. Chem. – volume: 80 start-page: 1564 year: 2007 end-page: 1571 ident: bib102 article-title: Blood-brain barrier transport of pramipexole, a dopamine D2 agonist publication-title: Life Sci. – volume: 70 start-page: 572 year: 2008 end-page: 577 ident: bib6 article-title: Synthesis and pharmacological evaluation of azetidin-2-ones and thiazolidin-4-ones encompassing benzothiazole publication-title: Indian J. Pharmaceut. Sci. – volume: 13 start-page: 226 year: 2017 end-page: 238 ident: bib8 article-title: Anti-inflammatory, analgesic and anti-ulcerogenic activities of novel bis-thiadiazoles, bis-thiazoles and bis-formazanes publication-title: Med. Chem. – volume: 51 start-page: 1818 year: 2007 end-page: 1821 ident: bib70 article-title: activities of isavuconazole and other antifungal agents against Candida bloodstream isolates publication-title: Antimicrob. Agents Chemother. – volume: 104 start-page: 209 year: 1997 end-page: 228 ident: bib104 article-title: Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexole publication-title: J. Neural. Transm. – volume: 12 start-page: 859 year: 2019 end-page: 865 ident: bib129 article-title: Avatrombopag for the treatment of thrombocytopenia in patients with chronic liver disease publication-title: Expet Rev. Clin. Pharmacol. – volume: 336 start-page: 791 year: 2011 end-page: 800 ident: bib115 article-title: Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosapride publication-title: J. Pharmacol. Exp. Therapeut. – volume: 9 year: 2014 ident: bib120 article-title: Mechanisms of improved aortic stiffness by arotinolol in spontaneously hypertensive rats publication-title: PLoS One – volume: 5 start-page: 3526 year: 2014 end-page: 3530 ident: bib14 article-title: Synthesis and evaluation of some thiazole derivatives as an antifungal agent publication-title: Int. J. Pharm. & Life Sci. – volume: 22 start-page: 19 year: 1987 end-page: 22 ident: bib13 article-title: Synthesis and diuretic activity of imidazo [2, 1-b] thiazole acetohydrazones publication-title: Eur. J. Med. Chem. – reference: U. Yasutsugu, M.J. D, G. Jerzy, H.T. W, C. Chung-Pin, Process for Preparation of Water Soluble Azole Compounds, WO0152852A1.. – volume: 2 start-page: 261 year: 1999 end-page: 269 ident: bib80 article-title: HIV-1 protease inhibitor ritonavir modulates susceptibility to apoptosis of uninfected T cells publication-title: J. Hum. Virol. – volume: 27 start-page: 469 year: 1984 end-page: 527 ident: bib35 article-title: Ceftriaxone: a review of its antibacterial activity, pharmacological properties and therapeutic use publication-title: Drugs – volume: 6 start-page: 958 year: 1987 end-page: 962 ident: bib45 article-title: activity of a new broad spectrum, β-lactamase-stable oral cephalosporin, cefixime, Pediatr publication-title: infect. Dis. J. – reference: M. Takayama, N. Kurose, Pharmaceutical Composition Containing Optically Active Compound Having Thrombopoietin Receptor Agonist Activity and Intermediate Thereof, WO2009017098A1.. – volume: 185 start-page: 45 year: 2003 end-page: 49 ident: bib26 article-title: A comparison of the prophylactic efficacy of ceftriaxone and cefotaxime in abdominal surgery publication-title: Am. J. Surg. – volume: 28 start-page: 1065 year: 2006 end-page: 1078 ident: bib101 article-title: A review of the receptor-binding and pharmacokinetic properties of dopamine agonists publication-title: Clin. Therapeut. – volume: 19 start-page: 900 year: 1985 end-page: 906 ident: bib29 article-title: Ceftriaxone: a third-generation cephalosporin publication-title: Drug Intell. Clin. Pharm. – volume: 35 start-page: 2078 year: 1991 end-page: 2084 ident: bib52 article-title: Single-dose pharmacokinetics of ceftibuten (SCH 39720) in infants and children publication-title: Antimicrob. Agents Chemother. – volume: 12 start-page: 553 year: 2016 end-page: 562 ident: bib9 article-title: Synthesis, antibacterial activity, interaction with nucleobase and molecular docking studies of 4-formylbenzoic acid based thiazoles publication-title: Med. Chem. – volume: 21 start-page: 2123 year: 2012 end-page: 2132 ident: bib20 article-title: Thiazoles: having diverse biological activities publication-title: Med. Chem. Res. – volume: 108 start-page: p69 year: 2008 end-page: p78 ident: bib140 article-title: Effect of febuxostat on the progression of renal disease in 5/6 nephrectomy rats with and without hyperuricemia publication-title: Nephron. Physiol. – volume: 258 year: 2020 ident: bib30 article-title: Ceftriaxone improves hepatorenal damages in mice subjected to D-galactose-induced aging publication-title: Life Sci. – volume: 35 start-page: 2562 year: 1992 end-page: 2572 ident: bib10 article-title: Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitors publication-title: J. Med. Chem. – volume: 11 start-page: 909 year: 2012 end-page: 920 ident: bib92 article-title: Combinations of BRAF, MEK, and PI3K/mTOR inhibitors overcome acquired resistance to the BRAF inhibitor GSK2118436 dabrafenib, mediated by NRAS or MEK mutations publication-title: Mol. Cancer Therapeut. – volume: 154 start-page: 98 year: 2012 end-page: 106 ident: bib24 article-title: The antibiotic resistance characteristics of non-typhoidal Salmonella enterica isolated from food-producing animals, retail meat and humans in South East Asia publication-title: Int. J. Food Microbiol. – reference: T. Ohta, S. Komoriya, T. Yoshino, K. Uoto, Y. Nakamoto, H. Naito, A. Mochizuki, T. Nagata, H. Kanno, N. Haginoya, K. Yoshikawa, M. Nagamochi, S. Kobayashi, M. Ono, Preparation of Heterocyclyl Moiety-Containing Diamine Derivatives as Factor Xa Inhibitors, WO2004058715A1.. – volume: 40 start-page: 980 year: 1997 end-page: 989 ident: bib134 article-title: Effect of structural modification of enol-carboxamide-type nonsteroidal antiinflammatory drugs on COX-2/COX-1 selectivity publication-title: J. Med. Chem. – volume: 12 year: 2019 ident: bib105 article-title: Pramipexole prevents ischemic cell death via mitochondrial pathways in ischemic stroke publication-title: Dis. Model. Mech. – volume: 43 start-page: 1047 year: 1990 end-page: 1050 ident: bib61 article-title: Synthesis and oral activity of ME1207, a new orally active cephalosporin publication-title: J. Antibiot. – volume: 84 start-page: 952 year: 2018 end-page: 960 ident: bib130 article-title: Pharmacokinetic/pharmacodynamic drug-drug interactions of avatrombopag when coadministered with dual or selective CYP2C9 and CYP3A interacting drugs publication-title: Br. J. Clin. Pharmacol. – reference: R.P. Pioch, – volume: 97 start-page: 699 year: 2015 end-page: 718 ident: bib18 article-title: Recent applications of 1, 3-thiazole core structure in the identification of new lead compounds and drug discovery publication-title: Eur. J. Med. Chem. – reference: M. Numata, I. Mimamida, M. Yamaoka, M. Shiraishi, Toshio Miyawaki, Cephalosporin Derivatives, US4421912. – volume: 60 start-page: 6890 year: 2016 end-page: 6891 ident: bib68 article-title: activity of isavuconazole against Rasamsonia species publication-title: Antimicrob. Agents Chemother. – volume: 30 start-page: 494 year: 1987 end-page: 498 ident: bib107 article-title: Dopamine autoreceptor agonists: resolution and pharmacological activity of 2, 6-diaminotetrahydrobenzothiazole and an aminothiazole analog of apomorphine publication-title: J. Med. Chem. – volume: 78 start-page: 4004 year: 2018 ident: bib112 article-title: The H2 receptor antagonist nizatidine inhibits carcinogenesis in two rodent models of hepatocellular carcinoma publication-title: Cancer Res. – volume: 51 start-page: 3397 year: 2007 end-page: 3400 ident: bib63 article-title: efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model publication-title: Antimicrob. Agents Chemother. – volume: 13 start-page: 567 year: 2009 end-page: 572 ident: bib137 article-title: Manufacture of high-purity meloxicam via its novel potassium salt monohydrate publication-title: Org. Process Res. Dev. – reference: G.D. Vite, R.M. Borzilleri, S.-h. Kim, J.A. Johnson, Epothilone Derivatives, WO9902514A2.. – volume: 104 start-page: 244 year: 2015 end-page: 252 ident: bib95 article-title: Early vaginal opening in juvenile female rats given BRAF‐inhibitor dabrafenib is not associated with early physiologic sexual maturation publication-title: Birth Defects Res. B Dev. Reprod. Toxicol. – volume: 18 start-page: 257 year: 1980 end-page: 263 ident: bib41 article-title: Comparative activities of cefotiam and cefazolin against urinary tract infections with proteus mirabilis in mice publication-title: Antimicrob. Agents Chemother. – volume: 294 start-page: F710 year: 2008 end-page: F718 ident: bib139 article-title: Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome publication-title: Am. J. Physiol. Renal – start-page: 203 year: 2001 end-page: 204 ident: bib83 article-title: Epoxyalcohol route to hydroxyethylene dipeptide isosteres: a new synthesis of the diaminoalcohol core of HIV-protease inhibitor ABT-538 (Ritonavir) publication-title: Chem. Commun. – volume: 47 start-page: 6658 year: 2004 end-page: 6661 ident: bib89 article-title: Discovery of publication-title: J. Med. Chem. – volume: 5 year: 2010 ident: bib59 article-title: Enhanced publication-title: PLoS One – reference: R.B. Sykes, W.L. Parker, C.M. Cimarusti, W.H. Koster, W.A. Slusarchyk, 2-Oxo-1-azetidinesulfonic Acid Salts, US4775670A.. – volume: 10 start-page: 391 year: 1982 end-page: 395 ident: bib42 article-title: activity of cefotiam against bacteria of clinical interest publication-title: J. Antimicrob. Chemother. – volume: 76 start-page: 155 year: 2016 end-page: 158 ident: bib126 article-title: Lusutrombopag: first global approval publication-title: Drugs – volume: 49 start-page: 214 year: 2016 end-page: 219 ident: bib94 article-title: Anti-septic effects of dabrafenib on HMGB1-mediated inflammatory responses publication-title: BMB Rep – volume: 239 start-page: 406 year: 1986 end-page: 410 ident: bib111 article-title: Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs publication-title: J. Pharmacol. Exp. Therapeut. – volume: 32 start-page: 783 year: 1980 end-page: 786 ident: bib36 article-title: Ro-13-9904/001, a novel potent and long-acting parenteral cephalosporin publication-title: J. Antibiot. – volume: 56 start-page: 1273 year: 2012 end-page: 1280 ident: bib46 article-title: High-level cefixime-and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure publication-title: Antimicrob. Agents Chemother. – volume: 332 start-page: 343 year: 1999 end-page: 347 ident: bib15 article-title: Synthesis and hypnotic activity of new 4‐thiazolidinone and 2‐thioxo‐4,5‐imidazolidinedione derivatives publication-title: Arch. Pharm. – volume: 152 start-page: 2447 year: 1994 end-page: 2455 ident: bib57 article-title: Cefdinir (CI-983), a new oral amino-2-thiazolyl cephalosporin, inhibits human neutrophil myeloperoxidase in the extracellular medium but not the phagolysosome publication-title: J. Immunol. – volume: 52 start-page: 195 year: 1990 end-page: 200 ident: bib121 article-title: Characteristics of 125I-lodocyanopindolol binding to β-adrenergic and serotonin-1B receptors of rat brain: selectivity of β-adrenergic agents publication-title: Jpn. J. Pharmacol. – volume: 16 start-page: 2841 year: 2016 end-page: 2862 ident: bib22 article-title: A review on chemistry, synthesis and therapeutic importance of its derivatives publication-title: Curr. Top. Med. Chem. – reference: T. Takaya, H. Takasugi, T. Masugi, H. Yamanaka, K. Kawabata, 7-Acylamino-3-vinylcephalosporanic Acid Derivatives and Processes for the Preparation Thereof, US4409214A.. – volume: 82 start-page: 247 year: 2009 end-page: 254 ident: bib128 article-title: AKR‐501 (YM477) a novel orally‐active thrombopoietin receptor agonist publication-title: Eur. J. Haematol. – reference: H. Axel, G. Joel, Antitumor Combination of B-Raf, MEK, and EGFR inhibitors, WO2014066606A2.. – volume: 27 start-page: 3994 year: 2022 ident: bib4 article-title: Thiazole: a versatile standalone moiety contributing to the development of various drugs and biologically active agents publication-title: Molecules – reference: X. He, L. Du, J. Zhu, Y. Wang, Method for Preparation of Febuxostat, WO2011082623A1.. – volume: 4 start-page: 516 year: 1985 end-page: 526 ident: bib38 article-title: Aztreonam, a new monobactam antimicrobial publication-title: Clin. Pharm. – reference: Y. Kumar, N. Tewari, R. Aryan, B. Rai, H. Nizar, Process for the Preparation of Cefpodoxime Acid, US20050020561A1.. – volume: 40 start-page: 1468 year: 1987 end-page: 1470 ident: bib53 article-title: Synthesis and biological properties of 7β-[( publication-title: J. Antibiot. – reference: M.V. Thippannachar, D.D. Gulabrao, V.S. Popat, A Process for Preparation of Mirabegron and Alpha Cryatalline Form Thereof, WO2015044965A1.. – reference: W. Yong, W. Jian, D. Zexin, Y. Guiju, C. Xuejiao, J. Xiaojun, Method for Preparing Nitazoxanide, CN103159697A.. – volume: 6 start-page: 391 year: 2012 end-page: 405 ident: bib91 article-title: Dabrafenib and its potential for the treatment of metastatic melanoma publication-title: Drug Des. Dev. Ther. – reference: Z. Matej, G. Stanislav, A. Borut, Z. Rok, K. Ivanka, Novel Process for Synthesis of Pramipexole and its Pharmaceutically Acceptable Salts, WO2008097203A1.. – volume: 33 start-page: 759 year: 1993 end-page: 765 ident: bib56 article-title: Synthesis of 7-[α-( 2-amino-[2-14C]thiazol-4-yl)-α-(Z)-methoxyiminoacetamido]-3-(1-methylpyrrolldinlo)methyl-3-cephem-4-carboxylate hydrochloride ([14C] cefepime hydrochloride) publication-title: J. Label. Compd. Radiopharm. – volume: 136 start-page: 784 year: 2015 end-page: 796 ident: bib99 article-title: BYL719, a new α‐specific PI3K inhibitor: single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma publication-title: Int. J. Cancer – reference: Y. Nishitani, Cephalosporin Having Catechol Group, WO2010050468A1.. – volume: 62 year: 2018 ident: bib65 article-title: antibacterial properties of cefiderocol, a novel siderophore cephalosporin, against Gram-negative bacteria publication-title: Antimicrob. Agents Chemother. – volume: 1 start-page: 32 year: 2009 end-page: 38 ident: bib17 article-title: Synthesis and biological evaluation of some 3-(methoxy phenyl)-2-aryl-thiazolidin-4-one derivatives publication-title: Indian J. Pharmaceut. Sci. – reference: Y. Kumar, M. Prasad, A. Prasad, S.K. Singh, N.P. Kumar, Preparation of Crystalline Cefdinir Potassium Dihydrate, WO2003050124A1.. – volume: 2 start-page: 75 year: 2003 end-page: 107 ident: bib55 article-title: Cefepime: a review of its use in the management of hospitalized patients with pneumonia publication-title: Am. J. Respir. Med. – volume: 9 year: 2014 ident: bib23 article-title: efficacy of the combination of ciprofloxacin and cefotaxime against vibrio vulnificus sepsis publication-title: PLoS One – ident: 10.1016/j.ejmech.2023.115172_bib131 – volume: 78 start-page: 4004 year: 2018 ident: 10.1016/j.ejmech.2023.115172_bib112 article-title: The H2 receptor antagonist nizatidine inhibits carcinogenesis in two rodent models of hepatocellular carcinoma publication-title: Cancer Res. doi: 10.1158/1538-7445.AM2018-4004 – volume: 8 start-page: 275 year: 2009 ident: 10.1016/j.ejmech.2023.115172_bib87 article-title: Discovery of ixabepilone publication-title: Mol. Cancer Therapeut. doi: 10.1158/1535-7163.MCT-08-0999 – volume: 6 start-page: 391 year: 2012 ident: 10.1016/j.ejmech.2023.115172_bib91 article-title: Dabrafenib and its potential for the treatment of metastatic melanoma publication-title: Drug Des. Dev. Ther. – volume: 56 start-page: 1273 year: 2012 ident: 10.1016/j.ejmech.2023.115172_bib46 article-title: High-level cefixime-and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.05760-11 – ident: 10.1016/j.ejmech.2023.115172_bib86 – volume: 62 year: 2018 ident: 10.1016/j.ejmech.2023.115172_bib65 article-title: In vitro antibacterial properties of cefiderocol, a novel siderophore cephalosporin, against Gram-negative bacteria publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.01454-17 – ident: 10.1016/j.ejmech.2023.115172_bib119 – volume: 52 start-page: 195 year: 1990 ident: 10.1016/j.ejmech.2023.115172_bib121 article-title: Characteristics of 125I-lodocyanopindolol binding to β-adrenergic and serotonin-1B receptors of rat brain: selectivity of β-adrenergic agents publication-title: Jpn. J. Pharmacol. doi: 10.1016/S0021-5198(19)40053-X – volume: 12 start-page: 859 year: 2019 ident: 10.1016/j.ejmech.2023.115172_bib129 article-title: Avatrombopag for the treatment of thrombocytopenia in patients with chronic liver disease publication-title: Expet Rev. Clin. Pharmacol. doi: 10.1080/17512433.2019.1649137 – volume: 4 start-page: 516 year: 1985 ident: 10.1016/j.ejmech.2023.115172_bib38 article-title: Aztreonam, a new monobactam antimicrobial publication-title: Clin. Pharm. – volume: 2 start-page: 75 year: 2003 ident: 10.1016/j.ejmech.2023.115172_bib55 article-title: Cefepime: a review of its use in the management of hospitalized patients with pneumonia publication-title: Am. J. Respir. Med. doi: 10.1007/BF03256641 – volume: 805 start-page: 118 year: 2017 ident: 10.1016/j.ejmech.2023.115172_bib142 article-title: Ameliorative effects of sildenafil and/or febuxostat on doxorubicin-induced nephrotoxicity in rats publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2017.02.046 – ident: 10.1016/j.ejmech.2023.115172_bib51 – start-page: 58 year: 1997 ident: 10.1016/j.ejmech.2023.115172_bib5 article-title: Vanadium-mediated chemoprotection against chemical hepatocarcinogenesis in rats: haematological and histological characteristics publication-title: Eur. J. Cancer Prev. doi: 10.1097/00008469-199702000-00010 – year: 2010 ident: 10.1016/j.ejmech.2023.115172_bib40 – ident: 10.1016/j.ejmech.2023.115172_bib28 – volume: 23 start-page: 3741 year: 2013 ident: 10.1016/j.ejmech.2023.115172_bib97 article-title: Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2013.05.007 – volume: 26 start-page: 3166 year: 2021 ident: 10.1016/j.ejmech.2023.115172_bib3 article-title: Thiazole ring-a biologically active scaffold publication-title: Molecules doi: 10.3390/molecules26113166 – volume: 19 start-page: 377 year: 1991 ident: 10.1016/j.ejmech.2023.115172_bib48 article-title: Comparative in vitro activity of cefpodoxime against anaerobes other than Bacteroides fragilis publication-title: Infection doi: 10.1007/BF01645372 – volume: 57 start-page: 1147 year: 1999 ident: 10.1016/j.ejmech.2023.115172_bib81 article-title: HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833 publication-title: Biochem. Pharmacol. doi: 10.1016/S0006-2952(99)00026-X – volume: 5 year: 2010 ident: 10.1016/j.ejmech.2023.115172_bib59 article-title: Enhanced in vivo activity of cefditoren in pre-immunized mice against penicillin-resistant S. pneumoniae (serotypes 6B, 19F and 23F) in a sepsis model publication-title: PLoS One doi: 10.1371/journal.pone.0012041 – volume: 92 start-page: 1 year: 2015 ident: 10.1016/j.ejmech.2023.115172_bib21 article-title: Thiazole: a promising heterocycle for the development of potent CNS active agents publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2014.12.031 – volume: 73 start-page: 574 year: 1989 ident: 10.1016/j.ejmech.2023.115172_bib33 article-title: Ceftriaxone diffusion from blood to aqueous humour in man publication-title: Br. J. Ophthalmol. doi: 10.1136/bjo.73.7.574 – volume: 7 start-page: 338 year: 2007 ident: 10.1016/j.ejmech.2023.115172_bib54 article-title: Efficacy and safety of cefepime: a systematic review and meta-analysis publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(07)70109-3 – ident: 10.1016/j.ejmech.2023.115172_bib39 – ident: 10.1016/j.ejmech.2023.115172_bib143 – ident: 10.1016/j.ejmech.2023.115172_bib66 – volume: 9 start-page: 79 year: 2016 ident: 10.1016/j.ejmech.2023.115172_bib67 article-title: Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections publication-title: Infect. Drug Resist. – volume: 27 start-page: 3994 year: 2022 ident: 10.1016/j.ejmech.2023.115172_bib4 article-title: Thiazole: a versatile standalone moiety contributing to the development of various drugs and biologically active agents publication-title: Molecules doi: 10.3390/molecules27133994 – volume: 2 start-page: 196 year: 2009 ident: 10.1016/j.ejmech.2023.115172_bib12 article-title: Synthesis and biological evaluation of some substituted amino thiazole derivatives publication-title: Asian J. Res. Chem. – volume: 284 start-page: 29798 year: 2009 ident: 10.1016/j.ejmech.2023.115172_bib85 article-title: Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level publication-title: J. Biol. Chem. doi: 10.1074/jbc.M109.029470 – volume: 28 start-page: 1065 year: 2006 ident: 10.1016/j.ejmech.2023.115172_bib101 article-title: A review of the receptor-binding and pharmacokinetic properties of dopamine agonists publication-title: Clin. Therapeut. doi: 10.1016/j.clinthera.2006.08.004 – volume: 32 year: 2018 ident: 10.1016/j.ejmech.2023.115172_bib136 article-title: Rutin and meloxicam attenuate paw inflammation in mice: affecting sorbitol dehydrogenase activity publication-title: J. Biochem. Mol. Toxicol. doi: 10.1002/jbt.22029 – volume: 17 start-page: 1193 year: 2009 ident: 10.1016/j.ejmech.2023.115172_bib125 article-title: Discovery of N-[(1R,2S,5S)-2-{[(5-chloroindol-2-yl)carbonyl]amino}-5-(dimethylcarbamoyl)cycloh exyl]-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamide hydrochloride: a novel, potent and orally active direct inhibitor of factor Xa publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2008.12.037 – volume: 10 start-page: 391 year: 1982 ident: 10.1016/j.ejmech.2023.115172_bib42 article-title: Vitro activity of cefotiam against bacteria of clinical interest publication-title: J. Antimicrob. Chemother. doi: 10.1093/jac/10.5.391 – volume: 76 start-page: 1835 year: 2005 ident: 10.1016/j.ejmech.2023.115172_bib138 article-title: Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase publication-title: Life Sci. doi: 10.1016/j.lfs.2004.10.031 – volume: 70 start-page: 572 year: 2008 ident: 10.1016/j.ejmech.2023.115172_bib6 article-title: Synthesis and pharmacological evaluation of azetidin-2-ones and thiazolidin-4-ones encompassing benzothiazole publication-title: Indian J. Pharmaceut. Sci. doi: 10.4103/0250-474X.45393 – ident: 10.1016/j.ejmech.2023.115172_bib100 – volume: 336 start-page: 791 year: 2011 ident: 10.1016/j.ejmech.2023.115172_bib115 article-title: Acotiamide hydrochloride (Z-338), a new selective acetylcholinesterase inhibitor, enhances gastric motility without prolonging QT interval in dogs: comparison with cisapride, itopride, and mosapride publication-title: J. Pharmacol. Exp. Therapeut. doi: 10.1124/jpet.110.174847 – volume: 11 start-page: 909 year: 2012 ident: 10.1016/j.ejmech.2023.115172_bib92 article-title: Combinations of BRAF, MEK, and PI3K/mTOR inhibitors overcome acquired resistance to the BRAF inhibitor GSK2118436 dabrafenib, mediated by NRAS or MEK mutations publication-title: Mol. Cancer Therapeut. doi: 10.1158/1535-7163.MCT-11-0989 – volume: 6 start-page: 1 year: 2021 ident: 10.1016/j.ejmech.2023.115172_bib79 article-title: Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease publication-title: Signal Transduct. Tar. – volume: 13 start-page: 1117 year: 2014 ident: 10.1016/j.ejmech.2023.115172_bib98 article-title: Characterization of the novel and specific PI3Kα inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trialsNVP-BYL719 PI3Kα inhibitor and predictive response modeling publication-title: Mol. Cancer Therapeut. doi: 10.1158/1535-7163.MCT-13-0865 – volume: 1 start-page: 32 year: 2009 ident: 10.1016/j.ejmech.2023.115172_bib17 article-title: Synthesis and biological evaluation of some 3-(methoxy phenyl)-2-aryl-thiazolidin-4-one derivatives publication-title: Indian J. Pharmaceut. Sci. – volume: 30 start-page: 871 year: 1992 ident: 10.1016/j.ejmech.2023.115172_bib37 article-title: Synergy with aztreonam and arbekacin or tobramycin against Pseudomonas aeruginosa from blood publication-title: J. Antimicrob. Chemother. doi: 10.1093/jac/30.6.871 – volume: 35 start-page: 2562 year: 1992 ident: 10.1016/j.ejmech.2023.115172_bib10 article-title: Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitors publication-title: J. Med. Chem. doi: 10.1021/jm00092a006 – volume: 97 start-page: 699 year: 2015 ident: 10.1016/j.ejmech.2023.115172_bib18 article-title: Recent applications of 1, 3-thiazole core structure in the identification of new lead compounds and drug discovery publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2015.04.015 – volume: 51 start-page: 1818 year: 2007 ident: 10.1016/j.ejmech.2023.115172_bib70 article-title: In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.01217-06 – volume: 6 start-page: 1542 year: 2008 ident: 10.1016/j.ejmech.2023.115172_bib123 article-title: DU‐176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles publication-title: J. Thromb. Haemostasis doi: 10.1111/j.1538-7836.2008.03064.x – volume: 108 start-page: p69 year: 2008 ident: 10.1016/j.ejmech.2023.115172_bib140 article-title: Effect of febuxostat on the progression of renal disease in 5/6 nephrectomy rats with and without hyperuricemia publication-title: Nephron. Physiol. doi: 10.1159/000127837 – volume: 40 start-page: 1468 year: 1987 ident: 10.1016/j.ejmech.2023.115172_bib53 article-title: Synthesis and biological properties of 7β-[(Z)-2-(2-amino-4-thiazoyl)-4-carboxy-2-butenoylamino]-3-cephem-4-carboxilic acid (7432-S), a new oral cephem antibiotic publication-title: J. Antibiot. doi: 10.7164/antibiotics.40.1468 – ident: 10.1016/j.ejmech.2023.115172_bib47 – volume: 9 year: 2014 ident: 10.1016/j.ejmech.2023.115172_bib120 article-title: Mechanisms of improved aortic stiffness by arotinolol in spontaneously hypertensive rats publication-title: PLoS One – volume: 47 start-page: 6658 year: 2004 ident: 10.1016/j.ejmech.2023.115172_bib89 article-title: Discovery of N-(2-chloro-6-methyl-phenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino) thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays publication-title: J. Med. Chem. doi: 10.1021/jm049486a – volume: 13 start-page: 226 year: 2017 ident: 10.1016/j.ejmech.2023.115172_bib8 article-title: Anti-inflammatory, analgesic and anti-ulcerogenic activities of novel bis-thiadiazoles, bis-thiazoles and bis-formazanes publication-title: Med. Chem. doi: 10.2174/1573406412666160920091146 – volume: 13 start-page: 567 year: 2009 ident: 10.1016/j.ejmech.2023.115172_bib137 article-title: Manufacture of high-purity meloxicam via its novel potassium salt monohydrate publication-title: Org. Process Res. Dev. doi: 10.1021/op900031h – ident: 10.1016/j.ejmech.2023.115172_bib114 – volume: 18 start-page: 257 year: 1980 ident: 10.1016/j.ejmech.2023.115172_bib41 article-title: Comparative activities of cefotiam and cefazolin against urinary tract infections with proteus mirabilis in mice publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.18.2.257 – ident: 10.1016/j.ejmech.2023.115172_bib58 – volume: 7 start-page: 792 year: 2021 ident: 10.1016/j.ejmech.2023.115172_bib75 article-title: Simeprevir potently suppresses SARS-CoV-2 replication and synergizes with remdesivir publication-title: ACS Cent. Sci. doi: 10.1021/acscentsci.0c01186 – volume: 84 start-page: 952 year: 2018 ident: 10.1016/j.ejmech.2023.115172_bib130 article-title: Pharmacokinetic/pharmacodynamic drug-drug interactions of avatrombopag when coadministered with dual or selective CYP2C9 and CYP3A interacting drugs publication-title: Br. J. Clin. Pharmacol. doi: 10.1111/bcp.13517 – volume: 45 start-page: 244 year: 2013 ident: 10.1016/j.ejmech.2023.115172_bib141 article-title: Evaluation of effect of allopurinol and febuxostat in behavioral model of depression in mice publication-title: Indian J. Pharmacol. doi: 10.4103/0253-7613.111922 – volume: 5 start-page: 3526 year: 2014 ident: 10.1016/j.ejmech.2023.115172_bib14 article-title: Synthesis and evaluation of some thiazole derivatives as an antifungal agent publication-title: Int. J. Pharm. & Life Sci. – start-page: 203 year: 2001 ident: 10.1016/j.ejmech.2023.115172_bib83 article-title: Epoxyalcohol route to hydroxyethylene dipeptide isosteres: a new synthesis of the diaminoalcohol core of HIV-protease inhibitor ABT-538 (Ritonavir) publication-title: Chem. Commun. doi: 10.1039/b005804l – volume: 44 start-page: 142 year: 1998 ident: 10.1016/j.ejmech.2023.115172_bib25 article-title: Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children publication-title: Chemotherapy doi: 10.1159/000007106 – volume: 45 start-page: 1151 year: 2018 ident: 10.1016/j.ejmech.2023.115172_bib72 article-title: Efficacy and safety of fosravuconazole L‐lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: a multicenter, double‐blind, randomized phase III study publication-title: J. Dermatol. doi: 10.1111/1346-8138.14607 – ident: 10.1016/j.ejmech.2023.115172_bib96 – volume: 2018 start-page: 4196961 year: 2018 ident: 10.1016/j.ejmech.2023.115172_bib103 article-title: Ropinirole and pramipexole promote structural plasticity in human iPSC-derived dopaminergic neurons via BDNF and mTOR signaling publication-title: Neural Plast doi: 10.1155/2018/4196961 – ident: 10.1016/j.ejmech.2023.115172_bib106 – ident: 10.1016/j.ejmech.2023.115172_bib50 – volume: 17 start-page: 258 year: 1998 ident: 10.1016/j.ejmech.2023.115172_bib34 article-title: Penetration of ceftriaxone into the middle ear fluid of children publication-title: Pediatr. Infect. Dis. J. doi: 10.1097/00006454-199803000-00022 – ident: 10.1016/j.ejmech.2023.115172_bib44 – ident: 10.1016/j.ejmech.2023.115172_bib73 – volume: 12 year: 2019 ident: 10.1016/j.ejmech.2023.115172_bib105 article-title: Pramipexole prevents ischemic cell death via mitochondrial pathways in ischemic stroke publication-title: Dis. Model. Mech. doi: 10.1242/dmm.033860 – volume: 18 start-page: 4853 year: 2008 ident: 10.1016/j.ejmech.2023.115172_bib74 article-title: Structure-activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350 publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2008.07.088 – volume: 61 year: 2017 ident: 10.1016/j.ejmech.2023.115172_bib76 article-title: Preclinical characterization and human microdose pharmacokinetics of ITMN-8187, a nonmacrocyclic inhibitor of the hepatitis C virus NS3 protease publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.01569-16 – volume: 32 start-page: 783 year: 1980 ident: 10.1016/j.ejmech.2023.115172_bib36 article-title: Ro-13-9904/001, a novel potent and long-acting parenteral cephalosporin publication-title: J. Antibiot. doi: 10.7164/antibiotics.33.783 – volume: 44 start-page: 190 year: 1997 ident: 10.1016/j.ejmech.2023.115172_bib78 article-title: Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir, Brit publication-title: J. Clin. Pharmacol. doi: 10.1046/j.1365-2125.1997.00644.x – volume: 16 start-page: 2841 year: 2016 ident: 10.1016/j.ejmech.2023.115172_bib22 article-title: A review on chemistry, synthesis and therapeutic importance of its derivatives publication-title: Curr. Top. Med. Chem. doi: 10.2174/1568026616666160506130731 – volume: 9 year: 2014 ident: 10.1016/j.ejmech.2023.115172_bib23 article-title: In vivo efficacy of the combination of ciprofloxacin and cefotaxime against vibrio vulnificus sepsis publication-title: PLoS One doi: 10.1371/journal.pone.0101118 – volume: 60 start-page: 6890 year: 2016 ident: 10.1016/j.ejmech.2023.115172_bib68 article-title: In vitro activity of isavuconazole against Rasamsonia species publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.00742-16 – volume: 27 start-page: 469 year: 1984 ident: 10.1016/j.ejmech.2023.115172_bib35 article-title: Ceftriaxone: a review of its antibacterial activity, pharmacological properties and therapeutic use publication-title: Drugs doi: 10.2165/00003495-198427060-00001 – ident: 10.1016/j.ejmech.2023.115172_bib82 – volume: 67 start-page: 1334 year: 1978 ident: 10.1016/j.ejmech.2023.115172_bib122 article-title: Synthesis and β-adrenergic blocking action of a new thiazolylthiopropanolamine derivative publication-title: J. Pharmacol. Sci. doi: 10.1002/jps.2600670944 – volume: 256 start-page: 266 year: 2016 ident: 10.1016/j.ejmech.2023.115172_bib93 article-title: Anti-inflammatory effects of dabrafenib on polyphosphate-mediated vascular disruption publication-title: Chem. Biol. Interact. doi: 10.1016/j.cbi.2016.07.024 – volume: 2 start-page: 195 year: 2000 ident: 10.1016/j.ejmech.2023.115172_bib1 article-title: Recent advances in the preparation of heterocycles on solid support: a review of the literature publication-title: J. Comb. Chem. doi: 10.1021/cc000002f – ident: 10.1016/j.ejmech.2023.115172_bib49 – ident: 10.1016/j.ejmech.2023.115172_bib109 – volume: 152 start-page: 2447 year: 1994 ident: 10.1016/j.ejmech.2023.115172_bib57 article-title: Cefdinir (CI-983), a new oral amino-2-thiazolyl cephalosporin, inhibits human neutrophil myeloperoxidase in the extracellular medium but not the phagolysosome publication-title: J. Immunol. doi: 10.4049/jimmunol.152.5.2447 – volume: 2 start-page: 261 year: 1999 ident: 10.1016/j.ejmech.2023.115172_bib80 article-title: HIV-1 protease inhibitor ritonavir modulates susceptibility to apoptosis of uninfected T cells publication-title: J. Hum. Virol. – volume: 64 start-page: 2597 year: 2004 ident: 10.1016/j.ejmech.2023.115172_bib60 publication-title: Cefditoren Pivoxil, Drugs doi: 10.2165/00003495-200464220-00009 – volume: 321 start-page: 642 year: 2007 ident: 10.1016/j.ejmech.2023.115172_bib132 article-title: Effect of (R)-2-(2-aminothiazol-4-yl)-4′-{2-[(2-hydroxy-2-phenylethyl) amino] ethyl} acetanilide (YM178), a novel selective β3-adrenoceptor agonist, on bladder function publication-title: J. Pharmacol. Exp. Therapeut. doi: 10.1124/jpet.106.115840 – volume: 33 start-page: 292 year: 2016 ident: 10.1016/j.ejmech.2023.115172_bib117 article-title: Physiologically-based pharmacokinetic and pharmacodynamic modeling for the inhibition of acetylcholinesterase by acotiamide, a novel gastroprokinetic agent for the treatment of functional dyspepsia, in rat stomach publication-title: Pharm. Res. (N. Y.) doi: 10.1007/s11095-015-1787-y – volume: 69 start-page: 585 year: 2005 ident: 10.1016/j.ejmech.2023.115172_bib32 article-title: Bacterial cell wall synthesis: new insights from localization studies publication-title: Microbiol. Mol. Biol. Rev. doi: 10.1128/MMBR.69.4.585-607.2005 – volume: 294 start-page: F710 year: 2008 ident: 10.1016/j.ejmech.2023.115172_bib139 article-title: Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome publication-title: Am. J. Physiol. Renal doi: 10.1152/ajprenal.00454.2007 – volume: 14 start-page: 2198 year: 2017 ident: 10.1016/j.ejmech.2023.115172_bib135 article-title: Meloxicam decreases the migration and invasion of CF41. Mg canine mammary carcinoma cells publication-title: Oncol. Lett. doi: 10.3892/ol.2017.6400 – volume: 185 start-page: 45 year: 2003 ident: 10.1016/j.ejmech.2023.115172_bib26 article-title: A comparison of the prophylactic efficacy of ceftriaxone and cefotaxime in abdominal surgery publication-title: Am. J. Surg. doi: 10.1016/S0002-9610(02)01125-X – volume: 104 start-page: 209 year: 1997 ident: 10.1016/j.ejmech.2023.115172_bib104 article-title: Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexole publication-title: J. Neural. Transm. doi: 10.1007/BF01273182 – volume: 6 start-page: 163 year: 2013 ident: 10.1016/j.ejmech.2023.115172_bib69 article-title: Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections publication-title: Infect. Drug Resist. – ident: 10.1016/j.ejmech.2023.115172_bib90 – volume: 9 start-page: 201 year: 2008 ident: 10.1016/j.ejmech.2023.115172_bib62 article-title: Ceftaroline fosamil, a cephalosporin derivative for the potential treatment of MRSA infection publication-title: Curr. Opin. Invest. Drugs – volume: 20 start-page: 3118 year: 1887 ident: 10.1016/j.ejmech.2023.115172_bib2 article-title: Ueber verbindungen des thiazols (pyridins der thiophenreihe) publication-title: Eur. J. Inorg. Chem. – volume: 19 start-page: 900 year: 1985 ident: 10.1016/j.ejmech.2023.115172_bib29 article-title: Ceftriaxone: a third-generation cephalosporin publication-title: Drug Intell. Clin. Pharm. – volume: 136 start-page: 784 year: 2015 ident: 10.1016/j.ejmech.2023.115172_bib99 article-title: BYL719, a new α‐specific PI3K inhibitor: single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma publication-title: Int. J. Cancer doi: 10.1002/ijc.29040 – volume: 11 start-page: 1979 year: 2019 ident: 10.1016/j.ejmech.2023.115172_bib19 article-title: Recent advances of thiazole hybrids in biological applications publication-title: Future Med. Chem. doi: 10.4155/fmc-2018-0196 – volume: 6 start-page: 958 year: 1987 ident: 10.1016/j.ejmech.2023.115172_bib45 article-title: Vitro activity of a new broad spectrum, β-lactamase-stable oral cephalosporin, cefixime, Pediatr publication-title: infect. Dis. J. doi: 10.1097/00006454-198710000-00034 – volume: 49 start-page: 214 year: 2016 ident: 10.1016/j.ejmech.2023.115172_bib94 article-title: Anti-septic effects of dabrafenib on HMGB1-mediated inflammatory responses publication-title: BMB Rep doi: 10.5483/BMBRep.2016.49.4.220 – volume: 43 start-page: 1047 year: 1990 ident: 10.1016/j.ejmech.2023.115172_bib61 article-title: Synthesis and oral activity of ME1207, a new orally active cephalosporin publication-title: J. Antibiot. doi: 10.7164/antibiotics.43.1047 – volume: 154 start-page: 98 year: 2012 ident: 10.1016/j.ejmech.2023.115172_bib24 article-title: The antibiotic resistance characteristics of non-typhoidal Salmonella enterica isolated from food-producing animals, retail meat and humans in South East Asia publication-title: Int. J. Food Microbiol. doi: 10.1016/j.ijfoodmicro.2011.12.032 – volume: 104 start-page: 244 year: 2015 ident: 10.1016/j.ejmech.2023.115172_bib95 article-title: Early vaginal opening in juvenile female rats given BRAF‐inhibitor dabrafenib is not associated with early physiologic sexual maturation publication-title: Birth Defects Res. B Dev. Reprod. Toxicol. doi: 10.1002/bdrb.21165 – volume: 40 start-page: 980 year: 1997 ident: 10.1016/j.ejmech.2023.115172_bib134 article-title: Effect of structural modification of enol-carboxamide-type nonsteroidal antiinflammatory drugs on COX-2/COX-1 selectivity publication-title: J. Med. Chem. doi: 10.1021/jm9607010 – volume: 12 start-page: 553 year: 2016 ident: 10.1016/j.ejmech.2023.115172_bib9 article-title: Synthesis, antibacterial activity, interaction with nucleobase and molecular docking studies of 4-formylbenzoic acid based thiazoles publication-title: Med. Chem. doi: 10.2174/1573406412666160201121310 – ident: 10.1016/j.ejmech.2023.115172_bib133 – ident: 10.1016/j.ejmech.2023.115172_bib71 – ident: 10.1016/j.ejmech.2023.115172_bib127 – volume: 32 year: 2020 ident: 10.1016/j.ejmech.2023.115172_bib116 article-title: Acotiamide attenuates central urocortin 2‐induced intestinal inflammatory responses, and urocortin 2 treatment reduces TNF‐α productions in LPS‐stimulated macrophage cell lines publication-title: Neurogastroent. Motil. doi: 10.1111/nmo.13813 – volume: 80 start-page: 1564 year: 2007 ident: 10.1016/j.ejmech.2023.115172_bib102 article-title: Blood-brain barrier transport of pramipexole, a dopamine D2 agonist publication-title: Life Sci. doi: 10.1016/j.lfs.2007.01.035 – volume: 26 start-page: 1158 year: 1983 ident: 10.1016/j.ejmech.2023.115172_bib7 article-title: N-(4-Substituted-thiazolyl) oxamic acid derivatives, new series of potent, orally active antiallergy agents publication-title: J. Med. Chem. doi: 10.1021/jm00362a014 – volume: 17 start-page: 4223 year: 2007 ident: 10.1016/j.ejmech.2023.115172_bib16 article-title: Design and synthesis of 1, 2-dithiolane derivatives and evaluation of their neuroprotective activity publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2007.05.036 – volume: 76 start-page: 155 year: 2016 ident: 10.1016/j.ejmech.2023.115172_bib126 article-title: Lusutrombopag: first global approval publication-title: Drugs doi: 10.1007/s40265-015-0525-4 – ident: 10.1016/j.ejmech.2023.115172_bib88 – volume: 239 start-page: 406 year: 1986 ident: 10.1016/j.ejmech.2023.115172_bib111 article-title: Actions of nizatidine, a selective histamine H2-receptor antagonist, on gastric acid secretion in dogs, rats and frogs publication-title: J. Pharmacol. Exp. Therapeut. – volume: 332 start-page: 343 year: 1999 ident: 10.1016/j.ejmech.2023.115172_bib15 article-title: Synthesis and hypnotic activity of new 4‐thiazolidinone and 2‐thioxo‐4,5‐imidazolidinedione derivatives publication-title: Arch. Pharm. doi: 10.1002/(SICI)1521-4184(199910)332:10<343::AID-ARDP343>3.0.CO;2-0 – volume: 21 start-page: 2123 year: 2012 ident: 10.1016/j.ejmech.2023.115172_bib20 article-title: Thiazoles: having diverse biological activities publication-title: Med. Chem. Res. doi: 10.1007/s00044-011-9685-2 – volume: 22 start-page: 19 year: 1987 ident: 10.1016/j.ejmech.2023.115172_bib13 article-title: Synthesis and diuretic activity of imidazo [2, 1-b] thiazole acetohydrazones publication-title: Eur. J. Med. Chem. doi: 10.1016/0223-5234(87)90169-3 – volume: 33 start-page: 759 year: 1993 ident: 10.1016/j.ejmech.2023.115172_bib56 article-title: Synthesis of 7-[α-( 2-amino-[2-14C]thiazol-4-yl)-α-(Z)-methoxyiminoacetamido]-3-(1-methylpyrrolldinlo)methyl-3-cephem-4-carboxylate hydrochloride ([14C] cefepime hydrochloride) publication-title: J. Label. Compd. Radiopharm. doi: 10.1002/jlcr.2580330812 – volume: 24 start-page: 862 year: 2022 ident: 10.1016/j.ejmech.2023.115172_bib108 article-title: Evaluation of 18F-flutemetamol amyloid PET image analysis parameters on the effect of verubecestat on brain amlyoid load in Alzheimer's disease publication-title: Mol. Imag. Biol. doi: 10.1007/s11307-022-01735-z – volume: 258 year: 2020 ident: 10.1016/j.ejmech.2023.115172_bib30 article-title: Ceftriaxone improves hepatorenal damages in mice subjected to D-galactose-induced aging publication-title: Life Sci. doi: 10.1016/j.lfs.2020.118119 – volume: 11 start-page: 2427 year: 2003 ident: 10.1016/j.ejmech.2023.115172_bib64 article-title: TAK-599, a novel N-phosphono type prodrug of anti-MRSA cephalosporin T-91825: synthesis, physicochemical and pharmacological properties publication-title: Bioorg. Med. Chem. doi: 10.1016/S0968-0896(03)00126-3 – ident: 10.1016/j.ejmech.2023.115172_bib124 – ident: 10.1016/j.ejmech.2023.115172_bib43 – volume: 30 start-page: 494 year: 1987 ident: 10.1016/j.ejmech.2023.115172_bib107 article-title: Dopamine autoreceptor agonists: resolution and pharmacological activity of 2, 6-diaminotetrahydrobenzothiazole and an aminothiazole analog of apomorphine publication-title: J. Med. Chem. doi: 10.1021/jm00386a009 – volume: 35 start-page: 2078 year: 1991 ident: 10.1016/j.ejmech.2023.115172_bib52 article-title: Single-dose pharmacokinetics of ceftibuten (SCH 39720) in infants and children publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.35.10.2078 – volume: 17 start-page: 19 year: 2008 ident: 10.1016/j.ejmech.2023.115172_bib11 article-title: Design, synthesis, and antimalarial evaluation of thiazole-derived amino acids publication-title: Med. Chem. Res. doi: 10.1007/s00044-008-9089-0 – volume: 51 start-page: 3397 year: 2007 ident: 10.1016/j.ejmech.2023.115172_bib63 article-title: In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.01242-06 – volume: 81 start-page: 1 year: 2020 ident: 10.1016/j.ejmech.2023.115172_bib113 article-title: Comparative histological and histochemical studies between ranitidine and nizatidine in treatment of peptic ulcer with evaluation of their adverse effects on male sex hormones publication-title: J. Basic Appl. Zool. doi: 10.1186/s41936-020-00196-6 – year: 2008 ident: 10.1016/j.ejmech.2023.115172_bib31 – volume: 18 start-page: 4853 year: 2008 ident: 10.1016/j.ejmech.2023.115172_bib77 article-title: Structure-activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350 publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2008.07.088 – volume: 22 start-page: 155 year: 1995 ident: 10.1016/j.ejmech.2023.115172_bib27 article-title: Cefotaxime twice daily versus ceftriaxone once daily: a randomized controlled study in patients with serious infections, Diagn publication-title: Microorg. Infect. Dis. doi: 10.1016/0732-8893(95)00080-T – ident: 10.1016/j.ejmech.2023.115172_bib118 – ident: 10.1016/j.ejmech.2023.115172_bib110 – volume: 82 start-page: 247 year: 2009 ident: 10.1016/j.ejmech.2023.115172_bib128 article-title: AKR‐501 (YM477) a novel orally‐active thrombopoietin receptor agonist publication-title: Eur. J. Haematol. doi: 10.1111/j.1600-0609.2008.01198.x – volume: 1 start-page: 209 year: 2010 ident: 10.1016/j.ejmech.2023.115172_bib84 article-title: Cobicistat (GS-9350): a potent and selective inhibitor of human CYP3A as a novel pharmacoenhancer publication-title: ACS Med. Chem. Lett. doi: 10.1021/ml1000257 |
| SSID | ssj0005600 |
| Score | 2.6432993 |
| SecondaryResourceType | review_article |
| Snippet | The development of heterocyclic derivatives has progressed considerably over the past few decades, and many new agents of synthetic and natural origin have... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 115172 |
| SubjectTerms | Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Antifungal Agents - therapeutic use Chemical synthesis Clinical application Heterocycles Heterocyclic Compounds Privileged scaffold Thiazole ring Thiazoles |
| Title | Application and synthesis of thiazole ring in clinically approved drugs |
| URI | https://dx.doi.org/10.1016/j.ejmech.2023.115172 https://www.ncbi.nlm.nih.gov/pubmed/36758304 https://www.proquest.com/docview/2775612798 |
| Volume | 250 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NT9swFH9CcBiXaXQDyjZkpIkTofmwY-dYVWMFBEICJG5W_BFIVdKqaSd1h_3t88sHhUOFtEuiWLZi-ee8j_j93gP4QVMulFLMU0ylHmXum1NBpDxuuHMOhDIRQ3Ly1XU8vKcXD-xhAwYtFwbDKhvZX8v0Slo3Lb1mNXvTPO_dOu3jrAfMYIeKjCOJj1KOu_z076swj7imobjO6HTRlj5XxXjZ0bOtjiTCyMkOFvBwnXpaZ35WaujsE3xs7EfSr6e4Axu26MCHQVu2rQPHN3Uy6uUJuVtxq8oTckxuVmmql5_hV391dk3SwpByWThrsMxLMsnI_ClP_0zGluB_P5IXpKVQjpekykP-2xpiZovH8gvcn_28Gwy9pqyCp52vMfcSG8dCx3EaKC1i5q5hRil6p2EYGD_jqbahwysxkW_9QAufaZYYzGQvFKV-tAubxaSw-0ACLJ9uE0UNzfAutHCuNhKdXXsW6i5E7WpK3eQcx9IXY9kGl41kjYFEDGSNQRe8l1HTOufGO_15C5R8s3ekUwvvjDxqcZUOJjwrSQs7WZQy5BzrhvJEdGGvBvxlLhE6WZFPD_77vV9hG58wli1g32BzPlvY7864mavDavcewlb__HJ4_Q_3x_bi |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwEB5BOcAFsbCwhX14JcSJqHnYsXOsqu2WBSqkLRI3K34Egropalqk8uvXkwfVHhDSXhLJsRXLnzOPeOYbgFOacqGUYp5iKvUoc9-cCiLlccOdcyCUiRgmJ1-P49Et_XXH7jZg0ObCYFhlI_trmV5J66al16xm7ynPe7-d9nHWAzLYoSLjySZsITsV68BW_-JyNF5HesR1Jorrj34XbTPoqjAv-_jHVqcSYeTEBwt4-JaGessCrTTRcA92GxOS9OtZfoANW-zD9qCt3LYPZzc1H_XqnEzW6VXlOTkjN2um6tUB_Oyvj69JWhhSrgpnEJZ5SWYZWTzk6ctsagn--iN5QdosyumKVFTkz9YQM1_elx_hdvhjMhh5TWUFTzt3Y-ElNo6FjuM0UFrEzF3DjFJ0UMMwMH7GU21DB1liIt_6gRY-0ywxSGYvFKV-dAidYlbYT0ACrKBuE0UNzfAutHDeNuY6u_Ys1F2I2tWUuqEdx-oXU9nGlz3KGgOJGMgagy54r6OeatqNd_rzFij5z_aRTjO8M_J7i6t0MOFxSVrY2bKUIedYOpQnogtHNeCvc4nQz4p8evzf7_0G26PJ9ZW8uhhfnsAOPsHQtoB9hs5ivrRfnK2zUF-bvfwXcjH5kw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Application+and+synthesis+of+thiazole+ring+in+clinically+approved+drugs&rft.jtitle=European+journal+of+medicinal+chemistry&rft.au=Niu%2C+Zhen-Xi&rft.au=Wang%2C+Ya-Tao&rft.au=Zhang%2C+Sheng-Nan&rft.au=Li%2C+Yan&rft.date=2023-03-15&rft.pub=Elsevier+Masson+SAS&rft.issn=0223-5234&rft.eissn=1768-3254&rft.volume=250&rft_id=info:doi/10.1016%2Fj.ejmech.2023.115172&rft.externalDocID=S0223523423000879 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0223-5234&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0223-5234&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0223-5234&client=summon |